epidemiologie de l`infection a herpesvirus humain type 8 au senegal

!"#"$ !! "!#$%&!' #%
&'(# )#(#' *+,- '"+'
! $( )%*% ) +( ! (, -(. ) /* 00
12 3!%$$ 4224
5 67
8( $ 3!, * '" ) - %) -
!$,'( - /! '# - !(
(/( - /! ("( ($%/ 9 - /! +( ! (, -(. ) /*
00 ):, !'#( ! - %(;
(<(
#. , #"/%,
22
7
(%#- 2
E
2
G
0 2
6
7 D
6
4
D
77
47 $(%/%*(% $ $! " "% #% $ 0%&! =>7? D D
77
44$(%/%*(% $ $( !*! ) $! 0 ' D D
74
1
D D
71
17((*: ' "@ $ 0%&! =76? D D
71
14 '" %% *@%'%&! D D
71
11((*: )! 8%! D D
7A
A D D
7>
A7!$%"$%*(% B % 8% C D
7G
AD4D !$%"$%*(% B % 8%8 C D
7G
EF
D
7J
> D
76
>7('%% D D
76
>4(*! ) )%'%(% )! 8%! D D
47
>1 "(%% 0 0("@%&! D D
47
G
H I F J
KJL D
44
DD
44
G7 (* ' ) (" % D D
41
G4,$ ' '!$%"$ D
4G
G1($()% ) ($'( D D
4J
GA ,'"@ ' )%//! ) !D D D
J
H I F J D D
4J
46
J7%(0 %* )%* D
46
J4%(0 %* %)%* D D
12
J1"(% ) !$( D
12
6 M F J KJL D
17
72D
M J N D D
14
1 2 2 2
11
7D (% ) $M@O"%($ D D
11
4 $(# ( % ) (*% $ 0%% $ 0% D D
11
4 7 M(**!%$ D
1A
4 P 4 M!% ) (*% $ 0% D
1E
4 P 1 ( ($$ ) %$%(% D
1E
4 P A M!% )M''! $ 0%
$ 0% D
1E
0 3 2 2
7 "!$(% )M!) D D
7D7D $:8' D
4 (%$ (*%/ D D
1G
1G
1G
16
47 (%$ D D
16
44(*%/ D
A2
1@ ) D D
A2
17 $ 0% J D D
A2
14 Q"$ %(% ) !$( D
A4
4 0 2 2
7 M D D
A1
A1
77"(%% ) $( " "!$(% )M!) $ $M %0% )! "$:8'D D
A1
74"(%% ) $( " "!$(% )M!) $ $MR0D D D
A1
7D1 "(%% ) $( " "!$(% )M!) $ %0% @ "%($%: R0 D
AA
7A"(%% ) $( " "!$(% )M!) $ $ Q D
AA
7E "(%% ) $( " "!$(% )M!) $ $M@ "%($%(% D
AA
7> "(%% ) $( " "!$(% )M!) $ $ $%! ) %)* D D
AE
7G "(%% ) $( " "!$(% )M!) $ $ $%! ) %)* S (<( D
AE
7J "(%% ) $( " "!$(% )M!) $ $( " /% )! ": D D
AE
76"(%% ) $( " "!$(% )M!) $ $( " /% ) $( ': D D
A>
772"(%% ) $( " "!$(% )M!) $ $ )%(0 %* D D
AG
4
D
AJ
47 "8($* 0$ #($ )! J D D
AJ
44 "8($* $ $ Q D
AJ
41
"8($* / *% ) $MR0 D D
A6
4A "8($* )! J $ $ $%! ) %)* D
A6
4E "8($* )! J $ $( " /% D
E2
4> "8($* )! J )%(0 %* D
E2
4G "8($* )! J @ "%($%(% D
E7
4J ! "((': #% $ 0%&! D
E7
4 0 2
E1
2
EE
DEDICACE
A mes parents
qui n’ont ménagé aucun effort pour mon éducation, pour leur soutien et leur réconfort dans
les moments difficiles et pour leur direction bienveillante. Les mots me manquent pour vous
témoigner ma reconnaissance.
Puissiez-vous trouver dans ce travail l’expression de ma profonde gratitude
A mes grands parents
dont je garde encore le nostalgique souvenir de la chaleureuse affection.
A mes petits frères et sœur Alvarès, M’bor, Nicolas, Guilène et Daniel
Soyez assurés de ma profonde affection, puissiez-vous trouver dans le travail de l’aîné que
je suis la motivation de faire beaucoup mieux.
A ma sœur Elisabeth
Ma reconnaisance pour tes conseils avisés et ton édifiante direction.
A ma sœur Marie-Louise, mes frères Das, N’diouga, Pierre
Soyez assurés de mon amour fraternel et de mon attachement
A mes oncles et mes tantes
Ma reconnaissance pour vos conseils et votre soutien
A mes neveux et niéces, Oumar, Samuel, Seynabou, Awa, Sally,
Momar Ngary, Djanor
Santé, longue vie et réussite
A Marianne Ndiaye et Clarisse Monnet
Votre exemple m’a inspiré, merci pour votre soutien.
A mes amis Bamba, Auguste, Edouard
Pour l’amitié qui nous lie.
Au Pr Cheikh-Saad BOYE,
Pour sa disponibilité.
Au Dr Ndeye Coumba TOURE-KANE
Pour votre direction et vos sages conseils, mes sincères remerciements.
A tous mes amis et collègues du Laboratoire de Bactériologie-Virologie Magueye SENE,
Halimatou DIOP-NDIAYE, Ibrahima DIAGNE, Fabien Niama, Ambroise AHOUIDI, Maguette
DIOP, Fatou SECK, Amy TOURE, Diakité, Djibril SAMBOU, Michel, Oumar SAGNA, Badji,
Codou, Madame NDOYE, Major Codou, Sira SIDIBE, Coumba, Awa Cheikh, Ouly, Astou, El
hadj, Bara, Farba, Renée, NIANG-DIALLO,Fatou SYLLA, Assane FAYE et Silman
DIAWARA.
au contact desquels j’ai appris l’esprit d’équipe.
Au Dr Astou GUEYE-NDIAYE
7
Pour sa disponibilité
A toute l’équipe du Laboratoire de Biochimie de l’Etablissement Public de Santé Aristide le
Dantec
A toute l’équipe du Laboratoire de Biologie de l’Hôpital Albert Royer particulièrement au
Major DIENG, Maïmouna THIAM, Moussa, Sonko.
Au Dr Gaston SARR,
Pour sa disponibilité
A tous mes maîtres du primaire à la Faculté.
A tous mes camarades de promotion,
Beaucoup de chance
Au Parent Inconnu,
Toutes ces personnes qui œuvrent de façon bienveillante à ma réalisation.
A notre Maître et directeur de thèse
Madame Aïssatou GAYE-DIALLO, Maître de Conférence Agrégé
Vous nous avez guidé tout au long de ce travail qui porte votre empreinte indélébile. Les
années passées à vos côtés nous ont permis d’apprécier vos qualités humaines et
professionnelles.
Votre rigueur et votre générosité nous ont particulièrement marquées.
Veuillez accepter, chère maître, l’expression de notre profonde gratitude et notre
indéfectible attachement.
A notre codirecteur de thèse
Docteur Ndeye Coumba TOURE-KANE
Les mots ne suffiraient pas pour exprimer toute notre reconnaissance. Vous avez participé
de façon décisive à ce travail. Vos conseils nous ont été très bénéfiques. Votre sens élevé des
rapports humains, votre amour du travail bien fait, votre disponibilité vous assurent l’estime de
tous. Recevez nos plus vifs remerciements.
A Notre Maitre et Président de Jury,
Monsieur le Professeur Souleymane MBOUP
Nous avons eu le privilège de bénéficier de votre enseignement de haute qualité et de vos
sages conseils. Vos qualités humaines et professionnelles sont exceptionnelles. Vos qualités
scientifiques font honneur à notre Faculté, à notre pays et à l’Afrique. Acceptez tous nos
remerciements et notre profonde reconnaissance.
A notre Maître et Juge
Monsieur le Professeur Moussa Fafa Cissé
C’est pour nous un réel honneur de vous compter parmi les membres de ce jury. Vos
qualités intellectuelles et votre sympathie font de vous un professeur distingué.
Nous vous remercions d’avoir accepté de juger ce travail.
A notre Maître et Juge
Monsieur le Professeur Salif Sow
Nous avons beaucoup admiré votre rigueur, vos compétences professionnelles et votre
4
courtoisie. Votre présence dans notre jury nous donne l’occasion de vous témoigner notre
admiration et notre profond respect.
1
A
(%#-
(%#-
Louange à Toi, YAH Dieu le Père Tout-Puissant par qui toutes choses sont. Merci
pour ce travail que Tu as permis. Puisses-Tu dans Ta Bienveillante
Toute-Puissance le bénir et m’accorder Ta direction pour que j’arrive à la
glorieuse Lumière de la Connaissance. Puisses-Tu faire de moi Joseph, celui que
Tu accrois et m’accorder beaucoup de Providence.
Par Jésus le Christ Notre Seigneur.
Amen
E
>
M@"8%! @!'(% ," J 3()% (""$ " 8%! ( *% (! (* ' ) (" % ! 8%! &!% (""(% S $( /('%$$ ) M ! 8%! )* !8 "( @(0 * $$D 766A 5678 )( $ $% )! (* '
) (" % %)%/%*(% #( ! ( #% $ 0% ' $*!$(%D
"!% ) '#! !) ' $*!$(% "'% )M( *% * 8%! (!
(* ' ) (" % %$$' '(% (!% S )M(! (//*% !' ($ * ''
$( '($()% ) ($'( K@,""$(% 0(0$% (% (0% / $$%*!$(%L $ $,'"@ '
)%//! ) ! $ ',$ ' '!$%"$D
M"%)'% $ 0% ) $M%/*% S "8%! @!'(% ," J (#$% "( $
) ! $( "8($* T $( "$!"( ) * !) ( //*! ! )
" "!$(% ()!$D
( "8($* *@U $ /( : "! * ! /%&! $ !)
)%" %#$ /(% )( $( "(% *($ (!($ T *")( $( "(%
**%)($ )%" )M(!*! ) "!#$% S * 3 !D
8( ! $$ %!(% ! ! '' " " )M!)% ! " "!$(% )
!3 ) 2 S 42 ( " ! V
'% $( "8($* )! J )( * 0 !"D
V
'% $ "(%*!$(% ) $M%/*% S J / *% ) "((': !)%
V
" ) (Q )M!) &!% "' ) '%!Q * '") $ ' ) )
G
('%% )! JD
": ! 8! ) $( $%(! ! Q" $ !$( ) $( "8($* )
* " "!$(% D
J
0 0 M ! 8%! (""(( S $( /('%$$ ) &!% * '" ": )M!
*(% )M"8%! @!'(% )M! 0() '# )M":* (%'($D !$ @!%
"8%! @!'(% )*% - * $ 8%! @"%&! @!'(% ) ''
) ," 7 S JD
$ M(0%)M! 0 !" ) 8%! S ,'% *!#%&! S #%*((% $%(% !$
(! ! )M! # #% " %&! T %$ 8$ "" $! " %) ' $*!$(% 8(% >
>
J2D72 7E2D72 )($ D $M8$ "" $( *("%) !8 ! !*!
/%#%$$(% ) (! " %&! (""$ 0!'D
! "@,% "(@ $ 0% *((*% "( ! "@ ': ) $(* )
*!*D
69
"!% 766A $ 8%! @"%&! ," J KJL 0!$%:' !8 "(
('"$%/%*(% 0%&! )( ! $ / ' ) (* ' ) (" % )( *(% *( )
'($()% ) ($'( ) $,'"@ ' )%//! ) ! 56782
6
Q%* /! " !8 " ! $( "'%: / % "( @(0 * $$D $ )M! !)
!%$%( ! ("" *@ ' $*!$(% "(%*!$%: - $M(($, ) $( )%//* )
"(% KL )*% "( %%, * $$2 5:6.,82
! ' 8%)* ! &!* (0: (! %8(! )! 0 ' *$$!$(%
&!* !*"%#$ )M(""(% S ! (0 %/*%!Q @(0 * $$D ($%: )!Q
#(&! )M #! "*%8' S "(% )M! $% ) '($()% ) (" %
K(* ' ) (" %L ) %! (% )! 'W' !3 %/* "( $ "(
('"$%/%*(% 0%&! KLD
/(0' )M ) )!Q #(&! )M(# ) )%0 "( ! U,' )
%*% - $( (' 7D (! ('"$%/%*(% 0%&! /! ($% S "(% ) /(0'
) %*% !%$%( * '' (' * $ &!* (' 74 (' 4A )*% "(
%%, * $$D 5:6.,8; (": $( $ (' * $%# "( )%0% U,'(%&! K(' 7LD (! ! )!Q%:' "(% )M(' * KX#(' 74 X#(' 4AL !%$% !%&!' (8* $ /(0' %! ) $( #(&! (* ' )
(" %D
(" S ' 8%)* ! ! ) 8!$$ &!*
(0: - $ " )!% )M('"$%/%*(% @,#%) (8* ) $M %!$(% '($D ":
! !8$$ )%0% U,'(%&! %$ M !%8% ! )%: ('"$%/%*(% ;@,#%)(% !%$%( * '' (' * #(' 74 4AD
!$( ( $( '% 8%)* ) )!Q /(0' 112 (' >17 ('
"*%/%&! ) (* ' ) (" % &!% (""$ $ $ /(0' )M %! )
$% ) (* ' ) (" % )M! !3 %/* "( $ D &!* M@,#%) "(
(8* ) *@(%$$ )M ) $,'"@ *, %/* "( $M % (8* $M )
&!% ! $ )!Q %*%'% * '' (0 )! (* '
) (" %D
@ ' $ 0% ( (' % !8 $ )!Q /(0' "*%/%&! )
$% ) (" % $ 0 ' ) 8%! @"%&! (""(( S $( ! /('%$$ )
")( ! $% $( "* ) * /(0' $ (* ' ) (" %
( *% (! %)( M( "! W (#$% "( $ (8(!Q ) @(0 * $$D &!% &!() 'W'
" &!M%$ M(0% )M! 8%! @"%&! @!'(% $( &!% * $ %(% 8 $ % $ $% ) (* ' ) (" %D ( S $( )%//* ) (8(!Q "*) *@*@( ! (0
( *% (! (* ' ) (" % * !) ( ' &! * /(0' (% "
)( ! $ *@(%$$ )M ) $% ) (" % *@U ! 0() '# ) "(%
($ &! *@U * 'W' "(% $ %! (% * (% "! 56782
'' $ !"*(% @(0 * $$ )M(! (!! ! * $$ 766> 5<<8
"!% %"$ * $$ 766J 5=>8 "! "( $( !% )' $M@ ' $ 0% $
&!* 112 (' >17 (' *(% &!* ) 0 ' ) 8%! )
$( !/('%$$ ) *( S * ) ! !8(!
0 $ 0 * '"( ! !$ ":* @!'(% - "8%!
( *% (! K(" %M (* '(( *%() "%< 8%! ! L '(%(
) '' ," J K JLD 8%! @"%&! %'% K
L (""(% S * !8(! 0D
72
0 ?9
8%! *$( $ 4 *%: - $! " "% #% $ 0%&! $( !*! ) $!
0 'D
?969 #,,@A#"+' ,+' B%, %+%C"C, .++(DB, 5=68
( $ " "% #% $ 0%&! $M(** ( '% ! $( "*%/%*% )M@O $( )! )!
*,*$ "$%*(%/ $( $ *((*: ) $M%/*% D %% $ *$( 1 !/('%$$ "8%%( $ Y "8%%( "8%%(D
?96969 +B,9@# , M%/*% (!$$ ) /(Z 0($ "*%/%&! )M! ":* (%'($ ) '(%
"! Q"%'($' %/* )M(! ":*D
V
*,*$ ) "$%*(% 8%($ : ("%) - [ S 4A @D *$$!$ %/*
" ! // *, "(@ 0: *((*%%&!D
V
M%/*% $( %:0 %$$' )( $ 0(0$% 8!Q '(%
)M(! %! "!8 0($' @#0 $ 8%!D
8%! @!'(% ) * !/('%$$ $ !%8( -
#.#B 0 A#,,@A#"+' , E%B, # ,+B,9@# , %'"$Q8%!
(%*$$ 8%!
":*
!'( "8%! 7
' * !(
" %'"$Q8%! 7
#8%(% 7 ! 7
4 ! 4
1 ! N
?969?9+B,9@# , F M%/*% (!$$ $%'% S ! ":* (%'($ %#$ K"* )M@O : %LD
V
*,*$ ) "$%*(% 8%($ % B 8% C M( $%! 0($ &! )( $ /%# #$(
) $M":* %#$ S $M%/*% (!$$D *,*$ ) "$%*(% : $ 0
K"$!%! 3 !LD // *, "(@ 0: "! W #8 )( $( *$$!$ %/* T
* // *, "(@ 0: )8$ "" / , ) ( ) 0() *$$!$
K*, '0($%L 8 $!( $' 8 $( $,D $ Q% ) %*$!% !*$(%
K%*$!% ) ," ) \),L
V
M%/*% $( %:0 B % 8%8 C (! %8(! ) "$!%! %! - 0$() ($%8(%
77
0(0$% % $,'"@ *,D
#.#B 0 A#,,@A#"+' , E%B, # ,+B,9@# , F , '0($ 8%!
$ 8%!
":*
"
#
' * !(
!
"
#
#8%(% ! E
>
G
?969>9+B, @# , V
"* )M@O )!% S $M":* %#$ S $M%/*% (!$$ ! S )
":* &!% " *@ T
V
*,*$ ) "$%*(% ) 8%! ) * 0 !" M( $%! B %8% C &! )( $
$,'"@ *, )( *(% *( )( $ *$$!$ "%@$%($ $ /%# #$( T
V
M// *, "@( 0: M "( !3 ! 8%)D
#.#B 0 A#,,@A#"+' , E%B, # ,+B,9@# , ,'"@ *%" 8%!
@()% 8%!
":*
$
"8%! (%'%%
' * !(
%
& "8%! (%'%%]
#8%(% A ! ]Q*"% $$' ! (8 *% ! 8%! (%'($ $M **!* ! 8%! %'%
&!% %)!% ! $,'"@ ' *@U $ %0 )M'%&! &!% 8( %8% )( $M%)%/%*(% )! )% 8%! @"%&! @!'(%D
?9?9#,,@A#"+' ,+' # ,"%BA"B% B% (C'+
! $ 8%! @"%&! " :) (! %8(! ) $! 0 ' ) &!*
"D $ M(0% ) &!* " %8 ! ) "%% ) &!* )
'W' %(% D
0 !"' ) * &!* ( "'% ) *$( $ E *$(
) S D &!* '% 8%)* 0R* S ) %'(0 ) '%* * "%
$* %&! * /%' "( $( !% "( ) (($, S $M(%) )MU,' ) %*% K(#$(! LD
#.#B 0 #,,@A#"+' , E%B, -%C"DB, -B#', ,+' B% (%+B (C'+DB
74
0 %0(% 7
4
1
A
E
>
G J
! /('%$$
Y
Y
Y
^ _
>G
>6
A>
E6
EJ
AA
>4 JE
!" 0 '%&!
>9
>969#%#A"/%, +%-++(DB, 56G8
%// !) "(%*!$% $( '%* * "% $* %&! * $ (% 0(%8 "'% ) ' &!M%$ M(0%(% ) 8%! 8$ "" )M! )%(': * '"% 742 S
422 'D $M%%! 8 $MQ%! !8 V
,(! ! * &!% * %! "( $M )! 8%! !$ (! ! )M! !*!
" %&! /%#%$$(%D '%(% ) /%# (* S $( /(* % ) $(
*("%)D
V
( !*$ *("%) &!% ) ,'% %* ()%&! (8* 7>4 *(" ': K7E2
@Q(': 74 "(':LD $$ ( ! )%(': )M8% 772 'D
V
0!' &!% * '" ) '(%$ /%#!Q &!% ! $( *("%) 3 ! !
O$ %'" ( ) 3 *% $M8$ "" $( !*$ *("%)D
M8$ "" ! ""$ ) /% $( (%$$ )/%%%8 )! 8%% D M ! ) !#$ /!%$$
)%8 ) ''#( *$$!$(%D 0$,* " % 8%($ % )( $M8$ ""
/ ' ) " 3*% K"%*!$L T $ (%* " !($%( (0% * *
!*!D M8$ "" * /: (! 8%% ( 0() /(0%$% $$ ( ! (%0%*%
"*%/%&! " ! *@(&! "8%! %0% * )%% $M%/*%8% ) $( "(%*!$
8%($D
>9?9++,"+' A-DB
" % ) $( *("%) $ 0$,* " % )M8$ "" * %! G2_ )! " %)
)! 8%% D * '" (! ' % 42 " $,""%) )%//D
M * %! G_ )! " %) )! 8%% $! _ * '"% 14 GE_ K8 %
(#$(! LD
$%"%) " 44_ ) * " %)D $ M(0% ) "@ "@ $%"%) )%8 ) $(
''#( !*$(% ) $( *$$!$ @OD
71
@,)( ) *(# * %! 4_ )! " %) )! 8%% D
'' ! $ 8%! 8$ "" $ J %(#$ S $( '"(! ('#%(
K425L %(*%8 "( $ $8( ) $%"%) K@ @$ / 'LD
>9>9#%#A"/%, B E%B,
(8(!Q ) %3! 9! * $$D 5G<8 "'% )M #% $( !*! %)%'% $$ )!
J "( *, '%* * "% $* %&! * !*% "( )%(! &!% 8%!($% !
* &! ) *("%) * '" ) 74 "(': 7E2 @Q(': 142 %"$Q ((0
%* (:)D *("%) )! J " #(!* !" ) '#$(* !*!($
(8* $( *("%) ) 7 S )!Q )%//* ": &!% V
@Q(': " "( $( / ' ) * $% (!Q !!% )
@Q(': ) 7
V
$ %"$Q ) J (""((% "$! "% ' % ($$ 0 &! *!Q ) 7D
! ' % E " % "%*%"($ 8 " #(#$' W %'"$%&! )( $M('#$(0
) $( *("%) ) J , * '"% ! " % * ) "( $M 7G $( " % "%*%"($
) *("%) K* ) ; 4EL 1 (! " % ) *("%) "$! "% K* ) ;
>44>>ELD
/(0' 112 (' "( ( "@( ) $*! !8 54> K 4>L * ) " !
! " % (,( "$! ) E2_ )M@ ' $ 0% (8* $( " % ) *("%) 41 ) D
/(0' ( (!% ! @ ' $ 0% )M8% A2_ (8* $( " % ) *("%) ) $M
K 7L 56?3:=8D
'W' $ /(0' >17 (' * ) " ! ! /(0' ) " % @ ' $ 0!
) $( " % ) 0!' )! K GEL ) $M K 7$ 5673<<82
"(% ) #(&! )M ) !3 (% ) (* ' ) (" % )M(!
/(0' )! 0 ' ) $M(0 *(!($ "!(%/ %)%/% "( @,#%)(% (8* $
/(0' %%%(!QD ( *((*%(% ) * /(0' ())%% $ ( * /%' $( "(
(8* $ 0 ' ) 57:82
/(0' ()3(* (! /(0' 112 (' * ) " ! ! " % @ ' $ 0! S
$( " % '(3! ) *("%) ) K 4EL ) $M K 7LD $56782
/(0' ) 47 ' $( !**% ) 0: 8%(!Q (""( S *!Q )!
) $M "(%*!$% *!Q ) $( @,'%)% %( ) $( " % '(3! )
*("%) ) $( 0$,* " % (8* ! 0(%(% * $%(% S *$$ ) 0 ' )!
) $ML 56?3:78D (! /(0' ) 74 &!% * ) " ! ! " % )
''#( ! " % @ ' $ 0! ) *"! *$$!$(% * !"$ (!Q " % ! " % (($ 0! ) *,*$% " $ 'W' *((*%%&!D
( "( (%$$! )* !8 ) 0: 8%(!Q * )( " ! ) (($ 0! )
" % *$$!$(% %$!<% > *$P4D L 5<<82
0 ' )! J ( ! (%$$ * '"% 7>E 7G2 T _ ) JE_ ( ! $ 0!! J21 #"D $ * '" (! ' % JE "@( ) $*! !8 ) >> 7A
0 @ ' $ 0! S *$$ ) (! 8%! @"%&! $ (! "*%/%&! (! J )'% $( 0% &!% 3 ! ! O$ / )('($ )( $( "@,% "(@ $ 0% )! J
5G<82
'' " ! $ $( 0% *($ !%&! ) $M (% * '" )M!% )
()' "%%8 &!% * )(D !% %*@ 0!(% *, %
" 1E S AE "%% D ( "(%% M(% % !%/ ' % ,'%&! (! %8(!
) Q'% )! 0 ' 8%($ '(% $! '# (% /%Q T $( "* ) * !% S
$MQ'% EM )! 0 ' )! $(% "(0 $! O$ %'" ( )( $M * 0:
) * 8%!D M! ) Q'% (% "$! %*@ !% "%%8 '(% $! '#
(% /%QD (0! // !(' 57:8 ) * Q('% $( 0% * )( * " )(
)( $ 0 ' )! JL %$ !8 "( )M@ ' $ 0% (8* *$$ )! D ! $
J * 0% " ! !8(! 0: * )( " ! ! " % ('#((%
&!% " !8(% %8% ) /(Z 0!$ )!( $( "@( "* * ) $( "$%*(% $,%&! )!
8%!D 0% (% '' 7D
&!* /! $M #3 ) "$!%! *@*@ )! /(% ) %'"$%*(% )( $(
8(%(#%$% )! 8%!D // *M ! 0% 8(%(#$ &!% ( 'W' "'% ) )*% 1 )
A ! ," K L 71 8(%( )! J 5:63<>82 &!%" /(Z(% 5>78 (
) "$! %)%/% (! % ) * 0% &!% * '" 4J6 (*%) ('% K((L )!Q
) '(% @,"8(%(#$ 7 K(( E464L 4 K(( 76744JLD !) M( "! ( *%
!," "(@ $ 0% '(% $MQ%* ) * 8(%( 8( W $ !"" )
$M"%)'% $ 0% ' $*!$(% ) * !8(! 8%!D (8(%$ ($% (8* ) "$:8'
U('#% "( )$S $M"%)'% $ 0% ' $*!$(% $% $ 8(%( S $( 8%!$* ! S $(
('%% )! 8%! 5?G82
* $$D 57?3G?? ) $! * )' $ " %($% (/ '( )!
0: 7 )! J '#$(#$ S *$$ )! 0: K
(%'%% (/ '%0 %L )! 8%!
(%'%% #% &!M%$ M(% "( $8 )M@ ' $ 0% !*!($ $ )!Q 0:D $
* ! 8%! * '#%( '"$(Z( $M * 0: ) "( $ 0: 7 )
J T * 8%! %'' ($%(% $ $,'"@ *, "%'(% %)!%(% ! $,'"@ ' *@U
$ '(' !D
M(! "@( ) $*! !8 !)% " ! $! " "%
(%0%&! &!% / )M!Q ) *()%)( (!Q (*%/ ) )%(0 %* $ 0%&! )
$M%/*% (! JD
>E * ) " ! ! " % '#$(#$ S *$$ ) $M ) '' 1D M
! " % ) *("%) ) $MQ"% /(% ")( $ *,*$ ) "$%*(% $,%&! )!
8%!D " %) ' $*!$(% ) 7J $$ M ) * "( ! S /(% %)%&! S !
" % )! *,*$ $,%&! )*% (%!' (%0%&! ) $ " %) ' $*!$(%
) A2 5=H378 2
M G1 * ) " ! ! " % @(!' %''! (*%8 (($ 0! )
5?<37?378 $M(%0: !*$(% $( )! 8%! "%( KLD " % ) '' (%0: !*$(% ( *% S $( $(* )! J K(*, ( *%() !*$(
(%0 ! ! LD " %) ' $*!$(% ) 44441A $$ * '" 7>>4 ((D $$ " !(% W 8$ "" )!( $( "$%*(% $( )! 0 ' 8%($ (!
* ! ) $( '% ) $( *$$!$ @O ((*@( $M"% ' 8%($ S ) *@ ' '
7E
@OD ( *% % 8%8 % 8% S $MA K4L ) %$ %@%#
"*%/%&!' $M(*%8% ) "$%*(% (*%"% $$ "( $%(% (! ) '(% N 5:68D
KJL * ) " ! $( N K JL &!% (""(% S $( 0% #(%&!
$!*% U%"" /('%$$ ) /(*! (*%"% $D N M( *% (8* $ /(*!
*$$!$(% ) (*%"% E1 )%*' % 8% % 8%8 D %(*% *% $
) '(% N ) $( 0% N $( "(% *(# Q,$%&! '%($ ) $( E1D N #$ &! $M(*%8% (*%"% $$ ) $( E1 &!% &!% "( $M(" " % )
*$$!$ @O 5>82
!) /(% "( (' $$ ' &! $M JD7 " :) ) ""%)
(%0%&! &!% " ! # %#%$% "*%/%*% "*%8' 6>_ 66A_ 57=82
ME2 )! J * ) ! (*%8(! (*%"% $ 8%($ &!% $% (! " ' !
)! J %'!$ $( (*%"% ) 0: 8%(!Q "* * ()%/ (*%8( (%% $
*,*$ $,%&! )! JD ME2 $% (!Q " % *$$!$(% %)%0 %
KL % (*,$( KL (*%8( "%'( "*%8' $(
(*%"% 8%($ ) $ME2 (*%8 5GG82
E2 * ) (!% " ! $( " % &!% ! (*%8(! (*%"% $ S $(
/ % *(% !//%( " ! "!# $( $(* 8%($ (*%8 $MQ"% )
0: 8%(!Q )M(8($D M(! (*%8(% )! 0: "* * ! %'" ( (0% )!
J " ! " ) (!Q %'!$% 8% '(!Q (*%8 ) /(Z '(Q%'($ $ *,*$
$,%&! )! 8%!5?H8 D
!) * /(% )( ! " "!$(% * %! ) 7A "(%
!)(/%*(% "'% )M%)%/% ! !8(! !," - $ E ) $M (8* ! (!Q
) E6_ 5G682
( *@U $ "(% (% ) ',$ ' '!$%"$ $( "* )M! ! ,"
1 ) J (8* (! %8(! ) $M>E % ! !$ )$% ) "(% ) #( %
! !#%!% " %% 77476G ) $M>E 5:782
79
M8$ "" )! 8%! M((*@ S ) *"! ) $( ''#( *, "$('%&! ) $(
*$$!$ "!% (": "% *, ! /!% 8$ "" 8%($ ''#(
*, "$('%&! $( !*$ *("%) $%# )( $ *, "$('D
( *("%) '%0( S (8 $ *, "$(' )0() "( $ U,'
$, '%($ $ !*$ +) ": )( $ ,(! *$$!$(% K"! W "( $ " LD
M $( "@( )M(# "% "(% ) )*("%)(% &!% !%8% "( *$$ )
,@: ) (*%) !*$%&! ) " % )! 8%! )M*("%)(% !
"$%*(% T ,@: %)")( ) *$$ ) $M *$$!$(%D $$ ") "$(* )( $
,(! ) $( *$$!$ %/* '(% Q%0 ) U,' )M%/ '(% 8%($ "(%*!$% $(
@%'%)% %( KS $MQ*"% )! !
LD ! " $,'( )%//
7>
0 ) U,' @ ' $ 0! ) $( *$$!$ '($D ( * )%//* $ U,' 8%($
// ! *%#$ " ! $( *@%'% @("% $*%8 %*' (%8%($ "*!! )
$( ,@: ) $M *$$!$(% *, Q%&!D
( ,@: ) " % * ''* "( *$$ ) " % : "* *
#" #%I$D U,' *(% S $( ,@: ) * " % " #(#$' ,@% "( ) U,' *$$!$(% '(% "! Q*$! &!
&!$&! U,' % %* " )( $ "(%*!$ 8%($ (' (8* $$D
!% ! (8 $ " % "* * #%I$D " % ) U,' ('' ) U,' )M%/ '(% 8%($ &!% :0$ $( ,@: )M 8%($
K@,'%)% %( " $,'(LD
/% $ " % ()%8 #"$ $ " % ) !*! )! 8%% D
/ % $M ,@% $M('#$(0 ) $M ) " % 8%($
K,@% )( $ *, "$(' (" )( $ ,(!L ) (%(* (!Q
!*$ *("%)D M8$ "" /(% (! (8 )! %*!$!' ) "$('%&! &!% $
(" 3!&!MS $( !/(* ) $( *$$!$D
( '(0%($%(% ) $( *@ '(% $ %*$!% %(!*$(% *((*%%&! ) *$$!$ %/* "( $ "8%!D
7969B"A#"+' J ' E"%+ K
! (8 $8 "! ) ) ! $( #% $ 0% )! 8%! ( "$%*(% )! /(% ) $(
( ) *$$!$ "'%%8D $,'"@ *, (,( !#% ! (/ '(% $
*$$!$ %#$ $( '!$%"$%*(% )! J *% $M(3 ! )M! %'!$(D
,:' *$$!$(% !%$% "( $( "$!"( ) (!! * %! "( ) *$$!$ ) $,'"@ ' ) *(8% /&!'' ( *% (! (* ' ) (" % * ( !
: 0() '# ) * "% )! 0 ' )! J - *M $( $%0 7 " ! &
!
'& D (%' ) 7 (8* ! "@ # $ - $ 74
()*( ,$ "@ # $71(*( ! ( %)!% ! * %(* $,%&! )! J (8*
! (**!'!$(% 0() &!(% )! 0 ' 8%($ )( $ '%$%!D 5?<37:3<73<:8
(! $%0 %'%$(% '(% %/* S $( / % "( $( 4
"' $M!) "*% )! 0 ' )! J ! ! * &!% * * ( (%$$D 5<73<<8
* $$D 766> 5=?8 "! !%$% ! $%0 ) *$$!$ > &!% )
$,'"@ *, )%8 ) %/* "( J "( D
72?2 B"A#"+' J ' EE+ K
'' $ 8%! "%( $ 8%! @"%&! @!'(% ," J ! 8%!
$,'"@ "%&! ) $( "$%*(% /(% )( $ $,'"@ *, '"! 4 8 % *,*$ $,%&! *,*$ ) $(*D J 8%! : 8 %% )! 8%! "%( '!$%"$% (!% (! %8(! ) $M "@(,Q )( $( ($%8 57>82
7G
:9
," J "*%/%&!' ( *% S % '($()% @!'(%
*((*% "( ) " $%/(% !' ($ - $ (* ' ) (" % $( '($()% )
($'( $ $,'"@ ' )%//! ) !D
J !$' " )( $ $% "(/ % &!(% :
$8 '(% (!% )( $ *$$!$ (0!% ) /(Z * * '%( (!
)8$ ""' ) $( !'! ! 'W' "*)( $( !8! ) * !'! 56737>3682
!) ) @( *
%! *#(!Q ) 12 "(% "
* /%' &! $ O$ " %$ )!
"(%*!$% ")( ( (*%8(% )( $( '(3 % ) $( " "!$(% %0%/%*(% "(@ $ 0%&!D
$$D 5<8 //*! @% )( ) *@(%$$ )
! )* $( "* ) $M J "( J )( $( ! "(@ $ 0% )! %! *#($ "! W 0$%0 $ /(% &! J % !8
()!$ ) % W * %) )( $M%"(% ) (
( (%$$! $( )%%#!% ) $M%/*% S J )( $( " "!$(% 0($ "((.
W $%'% S *(% " "!$(% S %&! " ! $ (* ' ) (" %D
")( $( " ) &!* ) J $ ) $( '% *!$! ) $% )
(* ' ) (" % !#$(D $$ " !(% ()!% $( " ! $( $, 8% %)!% )
*$$!$ *%#$ )! J (!% #% &! $( ' )%/%*(% ) $( *% ) /(*! )
* %(* %)%"(#$ " ! $( '!$%"$%*(% 8%($ 56737>3682
/ * $(% $M> 72 )( $ "$('( (8* $( *@(0 8%($ S J
!00 &! ! * )!Q *, <% "!8 W %'"$%&! )( $( "(@ 0%
)! ) ) $,'"@ " $%/(%/ ( *% (! 8%! 5=82
! )*% ! ( *%(% '" $$ $( (*%8(% ) J $
)8$ ""' ) /%:8 !"% *!( @"(% *@U ! "(% %($% &!% ( Z!
! $%0 ) *$$!$ ) (0 "%"@%&! ) *@*@! %($% $ &! (%,"@% * '#% 4 ("" *@ *@%&! "( K 4> L ) $ 0%&!D
/(% &! J % )* )( ! *(% '# ) *$$!$ $%# )M*@(%$$ ) !' * $$* %'')%(' (8( ! ) /(Z * * '%( (8* $ ,'"O'
*$%%&! '(% )* )( ! *(% '# )M*@(%$$ ) !' * $$*
(": $( 0% ) ,'"O' (8( ("$((% ' ! $% *(!($ $M%/*% J $( (*%8(% !8! O KS "! ": $ "'% 12 3 !L (": $(
("$((% D ( )*% ) /(0' )M J (% "@': (% ( *%
S ! "%* '(% $%'% (!Q ,'"O' *$%%&! - /%:8 !"% *!( @"(% 5:?82
M! '(%: 0($ $M%/*% S J '#$ !%8 $ *@'( 0($ )
%/*% S @" 8%! @!'(% *MS)% ! %/*% *@ %&! (8* !
"%' %/*% !%8% )M! $(* " #(#$' * !" "( ) "% ) )
(*%8(% D
( "%' %/*% !8 (,'" '(%&! !% $ 8%! %/*(% ) /(Z 7J
0 $( ! "% '# ) $,'"@ *, 76 " %%/D
( $ (* ' ) (" % $( *% ) /(*! ) * %(* (!0'(% !
(*%8(% $( '!$%"$%*(% 8%($ )( $ *$$!$ !' ($ $ *$$!$ (0!% ($ 'W' &! $( '($()% !8(% * S ! () %/(*$%%&!D $!%! $(# ( %
)M(%$$! ' &! $ 0: ( )! $ *, <% " )!% "( $M%/*% 8%($ /(*%$%(% $( * %(* )! )( $ *!$! *$$!$(% ) 'W' &!
$M%''! )"% 5<>3G=82
( $ *( ) "$(% ( *% (! J K$,'"@ ' )%//! ) ! $( '($()% ) ($'(L $ 8%! %/* $ *$$!$ !' ($ $$'W' "(%*%"
(%% )%*' (! " *! "$(%&! * )( " ! ) (($ 0! )M * 0:
@!'(% ('' ! (($ 0! 4 (,( ! (*%8% (%(" "%&! ! (($ 0! )
$( *,*$% *("(#$ ) "@ "@ ,$ $( " % )! % #$( ' ) * ) )0$ $
*,*$ *$$!$(% T ! *"! * !"$ (!Q " % * %!%8' (*%8 !
(($ 0! %@%#%! ) $( " % K%/ " /(* L '($'
" (#$ ) $( ('%% )! %0($ ) $M%/ 5<G363:82 8%($ !""%'
$M%)!*% "( $M%/ ) $( " % 47 /(8 % (%% ! " $%/(% *$$!$(%
%* O$D
! * (% )( $ *( )! ',$ ' '!$%"$ $ '*(%' ) (/ '(% " " (% ) (! "((*%D
J (# ) *$$!$ ',$ '(! %/*(% (! * (* ) "$(' *,
!' (!Q ) *$$!$ ) $M8% ' !' ($ &!% " )!%(% (! ) $M>D
*$$!$ %/* " /(%#$ &!(% )( $ ("%(% ')!$$(% ` $$ %)*(#$ '(% M('"$%/% / ' % 8%8 D $$ "!8
!% "( )( $ (0 5<G382
( ! $ *( $ 0 ' )! J ( Q'% E $ 0: 7 &!% %'%$(% S $( 0% )! &!% (% $( 0% B (/ '( C )! 8%!D 0: 7 * ) " ! ! " )!% (,( ) *((*%%&! )M! 0$,* " %
''#((% " !(% (8 % ! O$ )( $( ()!*% )! %0($ 8%($ ) 'W' &! )(
$( ('%% $ )8$ ""' ) $M%/*% S J 5>G3682
=9
=969%#',,,+'
' ) ) ('%% )! J ( !*% ) '#! " $'%&! )( $ '%$%!
) $( *@*@D
=96969+ ,LB
$!%! !) %)%&! &! J Q!$$' ('%%#$ - ('(%(
76
)*@% * $$D 5G8 ' (! * 8 % ) ('%% (": ! !)
/(% ! ) /'' !) % (,( "$!%! "((% Q!$
8 % ) ('%% (% " %#$ )M(": $ !) ) ('#%$$( * $$D
/(% *@U ) @ Q!$ 56682 (8(!Q ) (% 5:=8 ) 766J %)%&! &! $(
('%% Q!$$ ( " !8 *@U $ @ ' Q!$ )8$ ""( ) (%* "
$( ( *% S ) %/*% Q!$$' ('%%#$D
// $ (8(!Q ) D)*@% * $$D5G8 8:$ (!% &! $( ('%% Q!$$ " %#$ '(% '#$ W $% S ! @(! %&! )M
D
('%% Q!$$ *% ) * (* %%' $ &! $ * (*
((!Q ! ! )*% *@U $ '%*(% $ )%( @ ' Q!$ !
#%Q!$ 5=3?G3>H363:82
J "! W 0($' ('% "( $ "' '(% * 8 % )
('%% )! J '% (8* ) 8 576363G737>82
* "$!%! !) ' &! $( ('%% Q!$$ " %#$ '#$
W $% (! '# ) "((% Q!$ (!Q ," ) "(%&! Q!$$ S $(
"* *% ) * (*D (% $$ M "( $( !$ 8 % ) )%'%(% )! 8%! T %$
Q% )M(! 8 % ) ('%% 5:<8 D
=969?9
# "%#',,,+' -+%M+'"#
( "8($* $8 *@U $ /( $ () $* (/%*(% ' &!
$M%/*% S J " !(% (8 % ! 8 % ) ('%% (! &! Q!$$ - $(
('%% @ %U ($ 5G782
// ) (%* " S J )* *@U ) "% /( )M/%&!
%($ *($ "( (,('( * $$D 766J 5:8T (% * $$D 76665?G8D (!% "('% ) /( ('%*(% #% &! $( "8($* (% (!0' (": $(
"!# * '' $M 8$ $$D 766> 5:H8 D !0()( $( ('%% ) J /(% $(0' (8( $MR0 ) $( "!# $( "8($* $8
K7 /( ! 6 ( ) (%* " (% JLD * ( "'% S (,('( * $$D )
* %) ! ('%% @ %U ($ )! J 5:82
=969>9 # ,#E
J %/*%!Q 0($' !8 )( $( ($%8 * &!% !00: (!% &! $(
('%% Q!$$ "! W %'" ( )( $( )%//!% ) $M%/*% J 5:<8D
$(*<# \ * $$D 5<8 !00 (! * ! )M!) &! $ 0$() ($%8(%
" !8(% W ) % ) "$%*(% "( * &! ) ('%% )! JD
!* ) ('%% ! ! #8 *@U $ /(D @U $M()!$ $(
('%% "( $( ($%8 *% ! * (* %%' $ &! $ $(% 0%($
5=3:82
!) /(% )( ! " "!$(% )M"(0 ' &! $( 8 % ($
* %! $M! ) "%*%"($ 8 % ) ('%% )! J )( $ "(, S /(%#$
42
0 )'%*% )! 8%!D
// $ !) /(% "( X @ (!< * $$D 5<?8 *@U ) @ ' Q!$ ' &! $MQ" %% ($ S $( ($%8 %/*%! (% ! /(*! ) %&! " %$ " !
$M(*&!%%% ) $M%/*% S JD M )! J %(% (! (%' "( $( ($%8(%D ( "$%*(% )! J )( $ *$$!$ '($ ) $M "@(,Q !
!* ) )%'%(% )! 8%! "( $( ($%8 57>82
=96979 %#',,,+' #"%+(/'
( ('%% %( 0: ! ! #8 *@U $ ("$( )M 0( $
'!$%(/! K@' "@%$L $ ) 0! '(% $ '*(%' ) * 8 % )
('%% "(($ "( * $!*%) 5:H82
@(! "8($* S J ( *@U ) "(% ) 0! " %%/
* '"( S ) @ ' Q!$ &!% (% "$! Q" 5<H8D
!) #( ! $( ('%% (": ("$((% )M 0( ' "( (% !""% * $$D 5:>8D X!&!M%*% $ !) ) * 8 % ) ('%% $ 0%&!D (% !""% !%$%( ) '@ ) ' $*!$(% ' &! *
8 % ) ('%% #% " %#$D $$ ( " !8 0R* S $( 8(%(#%$% ) @(!
%8(! #8 (8* $ 0: 7 $ " $,' "@%' )! 0: G1 )! 0 '
JD
( !8 *@U ! $ "(% ("$( ! %)% ) 722_ )
!*$ %) ) $( "$!"( ) 0% 8(%(#$ )! 8%! $( "* )! 0: G15:>8D
!) /(% *@U ) "(% (": ("$((% )M 0( ' &!
$ J 3 !(% ! O$ ) (*%8(% )( $( !8! ) "(@ $ 0% (": 0// 5><8D
=9?9#A"B%, ,,C'#"+' B E%B,
* )%% *% * '%&! "!8 W $( *(! )M! )%'%(% )! J
/%&! * '' *M $ *( (8* $M@"(% 563:82 * )%% ) 8%
*% * '%&! ( *% (!Q /(*! 8% '(!Q S $( " '%*!%
K* ('%(% ! $ %L "!8 Q"$%&! $( @(! "8($* ) J /%&! 5G36=3?G36H>3=82
=9>9 C#%""+' (C+(%#-DB
M! '(%: 0($ $ J ! 8%! S *'' )* !8 &!% " )( $ ' ) % '(% (8* ! 8(%(% 0 0("@%&! 57<82
)%//* #8 $ (!! !$(% ) "(%*!$(% $ *($
) " "!$(% ) $M*@(%$$ (0 ) !%$% ) $M%"(% ) !$(D
**%) $ J / ' "()! )( $( U ')%( T $ (!Q
"!8 ($$ 3!&!HS E2_ "( ("" (!Q (! $ *($% - ($ K6EA_L5?78D ($% $(
"8($* )! J 8(% 0 0("@%&!' (8* ) "8($* "$! $8 (!
47
!) 56=3G:82 * * / '' S $( "(%% )! (* ' ) (" % $M%/*% S
J /&! )( $ #(% ')%( '(% ( )( *(% U * ''
$ ( % )M'%&! Q*" *@U $ %) $ %''! )"%' $
("$( )M 0( 5=736H>82 '%&! )! ) )( )M(! "(% )
$M! " $( /&!* /(%#$ ($$( ) 1 S 72_ $ $ 0% 5G:82
! (8 (!% $8 ) "8($* )( *(% "(, ( &! $( " "!$(% !)% % "*% - (+% K46_L "!#$%&! '%%*(% K71_L !('($( K72_L
" ! $ (%* " $,%&!D
X('(+&! * "8($* 8(% %$$' (8* $ Q $MR0 - $
@ '' )!Q / % "$! (% "( $ J &! $ /'' KQ (% - 4;7LD MR0
' , ) !3 (% )M8% A2 ( )( $ )!Q Q 5:H3::82
/%&! $ ) * * "$! $ U )M)'% ) (* ' ) (" %
K/%&! *($ ) $MLD
!) /(% *'' "( 0$ * $$25?78 /%&! !#(@(%
('' (! 0 )' *(%&! (! \(( ( $8 $ !$( %)%&! )(
$ (#$(! !%8( 0
147 \(( K%)%0:L 7EE \((
K#( !L 7>7
_
>E
G6KGAJ1L
>6K>1GEL
>7KE1>JL
J>KJ764L
A6KA7EGL
J2KG1J>L
JD7
J4KGJJGL
JGKJ761L
G>K>6JAL
!%$%( $ DJD7 8($! ( ' ! @(! %#%$% K67722_L "*%/%*% K64722_LD
)!Q (! KL K>EL ! %#%$% ! "*%/%*% 8(%(#$
$ $( " "!$(% D !) /(% ! ! " "!$(% ) 3! ()!$ '(% $
*@*@! * ''* S M% ) "$! "$! (!Q U S /(%#$ )'% )!
(* ' ) (" %D
%, @% * $$D 5?8 !8 ! "8($* ) G6_ *@U $ /'' *%
0('#% ) (! $ 0%&! * ! - G1_ *@U $ 7 J1_ " ! $ 4D
!) /(% (! 0($ ! $( 'W' " "!$(% 8$ ) !$( ) $ %
%/%! - ! "8($* ) 7AD1 _ 5?82
*@*@ $ (%* " (%(%0: $(D
<9
N 4 $
44
0 <969 #%A+ O#+,
$ H(0% )H! !'! 8(*!$(% )*% " ! $( "'%: / % "( $ )'( $ 0! %U
(" % 7JG4 5=H82 H $H! ) "$(' $ "$! /&!'' !8 *@U
$ "(% %)D ( )* !8 %$ /! * %) * '' ! '($()% ( %) $ (//*( ! ! $ !3 ')%( 56:82
$! () $ (* ' ) (" % /! !8 *@U $ !3 (/%*(% )( *(%
0% ) $M/%&! "(%*!$% /%&! %($ 76>2D (* ' ) (" % ( ("" * '' "( 8% 72_ ) "$('D (* ' ) (" % (!% * ! (! ( % )M'%&! ! " (8( $M: )! %)( ('' *@U
$ %''! )"%' $ ("$( 56:3<>82
! $ "$( *$%%&! $ (* ' ) (" % "! '(%/ ! / ' )H(%
*!( !8 (! "'% "$( * %! ) "$(&! ,@'( (0% '(! )
!'/(*% "("!$ )!$(% "$! ! ' % (0% '(! 5:82 ")( )
'(%/(% Q(*!( $% (!Q )%// (% 8%*($ ; !
0(0$% (% "!8 W * 5<>82
! 8($! $ $% $( *@(0 8%($ ) J )! (0 "%"@%&! $M8 $!% )! (* ' ) (" % ) !3 *! "('% $ "(% * !$(% )'( $ 0%&! S $M@O"%($ (%,(\( ) (( (! N%'#(#\ ")( (%
X!% 766JD ": * ' ) "(% )!Q !# ) (0 * $$* " !
)!Q 8! ) !8 ) $H J )( $ "$('( )( $ *$$!$
' !*$ )! (0 "%"@%&! (": ('"$%/%*(% "( $( *@%&! )! K
4>LD
M8 $!% )! (* ' ) (" % ( )'% "( ("" (! " % *$%%&!D
V
"# 6 - % %) $ $ *($ T
V
"# ? - % *!( $ *($' (0%8 (8* ! ( )!$ $ *($ %*$! T
V
"# > - % *!( '!$%"$ ! ) )!$ %*$! ( (* ' ) (" %
8%%#$ ! ! 8%) ()% 0("@% "!$' (% ) (* ' ) (" % T
V
"# 7 - ($(($ (* ' ) (" % ! (* ' ) (" % 8%*($D
%& /'' ('%*(% 0(%8 (8(%$$( )( ) $(# ( % K46 ( )
' ,L *! * '' * O$ " ! $ #( %&! ) $H%/*% S JD
( * !) (! ($ 17 "(% " %%/ &!% " 'W' '" $
J Q('% ) 4> *( ) (* ' ) (" % K4E !3 () 1 A T 7
!3 (! () ) (* ' ) (" % K() 4L E "(% " %%/ ( "(% ) (* ' ) (" % (8* K^ ; LD
$H S J ( !8 )( $ "$('( ) !3 %/* S J ()% &!
*@U $ E !3 S ;
(!*! /(0' ) $H S J H( !8 *@U $
!3 (! () 4 ) /(0' )H S J !8 '(% (8* ! (!Q (!
) ! ) $( ' , K(!Q [ 4E2 *";'$LD
41
E
( * $ (! 12 !3 (8(% ! (!Q 4DG7DA 72 *";'$ *HS)%
!"%! S $( ' ,D ")( $ %8(! ) $M S J *@U $ !3 (
(* ' ) (" % K' , 4E;4 * "%;'$L (% %'%$(% * '"( (!Q !3
"( $ (* ' ) (" % K' , 1A>G 141> *";'$L " ! () 1 A $
%8(! ) $H S J )( $ "$('( M(% "( $% S $M8 $!% )! (* ' )
(" %D
! W *(% )! $% $( *@(0 8%($ )! (0 "%"@%&! ) J $M8 $!% ) %0 *$%%&! )! (* ' ) (" % ('"#$$ D * $$D !%$%
) *$$!$ ' !*$ )! (0 "%"@%&! " ! )* $H S J "( $(
*@%&! ) $( $,'( @(% (*% !%$%( $ 'W' "(% &! " ! $
"'% D !$( $ !%8( V
42_ ) E "(% ^;
"(% ) /(0' )H S J (8* !
' , [ S E * "%;0 T
V
J4_ ) "(% () 1 ) (* ' ) (" % "(% ) /(0' ) $H
J (8* ! ' , ) > * "%;0D T
V
722_ ) "(% () A ) (* ' ) (" % "(% ) /(0' )H
S J (8* ! ' , 0($ S AG6 * "%;0D
"$! #( %8(! ( )* *@U $H! ) E "(% 0(%/ * O$ )( $
*$$!$ ' !*$ )! (0 "%"@%&! 56?82
!) " *@U 7E N%'#(#\ $ %8(! ) $H S J
)( $ *$$!$ ' !*$ )! (0 "%"@%&! (% %' $% (! (! *$%%&!
)! (* ' ) (" % ) " %/* "( $ JD ! $ " (!
() A (8(% ! %8(! $8 ) /(0' )H S J )( $ *$$!$
' !*$ )! (0 "%"@%&!D !% #8(% ! )%//* %0%/%*(%8 "(
("" (! %8(! )H S J )( $ *$$!$ ' !*$ )! (0 "%"@%&!
" ! $ () 1 "( ("" (! () A K> * "% * AG6 * "%;0 L
* ! $% ( (#$% " ! $ () 1 ) *@(%$$ "$('(%&! )
*$$!$ ' !*$ )! (0 "%"@%&!D
(( ) * !$( ('"#$$ D D * $$D /%% "( * *$! &!H%$ , (8(% !
/ * $(% $ *@(0 8%($ S J ) $( "(@ 0% )! (* ' )
(" % 56?82
H(! !) "(%*!$% *$$ ) N(0 * $$D 56HH83 8! * /%' $
!$( ) ('"#$$ D * $$D
// N(0 * $$D "! 8($! $( "8($* )! J ( *%(% (8* $ (* ' ) (" % (! %$ !%$%( ! )H%''! /$! ** )(
72AA *@(%$$ ) !' ) GAG ) ! ) (0 G1 "(% (! 8%* )
!0* 44A "(% !%8( ! (%' ) )( ) *$%%&! ) %)( ) JJ
) 44A "(% (% " %%/ K ^L KA2 ^ AJ L 71> "(%
0(%/ K LD
(%* " (% S J !8 *@U 1A ) ! ) (0 KAD>_L *@U G "(% " (!Q 8%* ) !0* % 6D>_D ")( $
4A
0 " !*(0 $ "$! $8 ( !8 )( $ 0 !" ) %/*% Q!$$'
('%%#$ T 14 ) A2 "(% " %%/ (8(% ) (%* " (%$(( % J2_ G "(% 0(%/ % 7AD>_D
": * (8(!Q N(0 * $$D * *$! &! $( "* ) J *@U $
"(% " %%/ ( / ' * $ (! (* ' ) (" % *@U $ @ '' $
@ ' Q!$ *!Q (% )M@"(% '(% "( (8* $ (! &!% Q('%56HH82
$ * $$D 766J (8(% )* ) !*@ ) J )( 722_ ) #% "%
"$8 *@U ) /( U('#% !//( ) (* ' ) (" % )'%&! )
$M/(*D $ (8(% " " *$( * '' $( "'%: )' (% &! J " !8(%
W * %) * '' ! %/*% * ''! ) $M/(* 5=G82
! * ! ) * 'W' ( $ !$( ) * &!%" /! * /%' "(
(,('( $M(($, ) &!* ) !*@ ) J " 8( )M/( S $( / % 0(%/ "( ) (* ' ) (" % )'%&! ) $M/(*D $ !
%'" ( 8(%(% (! %8(! ) $( 0$,* " % 7 ) !*@ ) J
%)%/%5:82
* 8%*@ X * $$D 5>:8 (//%': 4222 !% S $! (8(!Q ! $ *( )
(* ' ) (" % * ! " '%&! /%&! &! "$!%!
/(*! %)!#%(#$ ! %0%/%*(% % $ 0%&! "(@ 0%&! )( $
)8$ ""' )! (* ' ) (" % *$(%&! T &! %&! $M%(*% * /(*!
(% * '"$%&! $( * '"@% * * ) $M%'" (* ) *@(&! /(*! )(
$M%)!*% $ )8$ ""' ) $( '($()%D
'' )( $ *( ) (! 8%! S @!'(% (/ '( $ *$$!$
$M%/*% "( J !$ %!//%( " ! $ )8$ ""' )! (* ' ) (" % %$
/(! $M())%% )M(! /(*! 5>:82 !) * ' &! $
)8$ ""' )! (* ' ) (" % $% S $( "* )! J ( *% )M(!
/(*! )! 8%! $ &! ( #% $ 0% ( "8($* )( )%// " "!$(% )M!) 5>:82
! $ "$( "%)'% $ 0%&! $ (* ' ) (" % *$( (* ' ) (" %
*$(%&! (* ' ) (" % (/%*(% (* ' ) (" % ( *% (! (* '
) (" % ( *% S $M%''! )"% D
<96969
# @+% A#,,DB +B J B%+C'' K
M ! / ' " ()%&! $(%8' (D $$ " ' % ) 7_ )
*(* %*%)* ) $M ) ) 122D222 "( ( ! " **%)($ (!Q
(% 995?82 %*%)* #(!* !" "$! $8 (! ! )! #(%
')%( K/%&! )! ) !&!% ($%L ! " ($ K!%*@ $ 0
!% ) $M!LD 'W' ($% * %*%)* ! ! )( $
!) K
()(%0L 5G:82
<969?9
# @+% ' CDB +B J #@%A#' K
$$ * ! ! U &!( %($ - ) ) $MQN(+
` $$
4E
" 3!&!MS 71_ ) !'! '($%0 ) $M@ ''D
( /&!* $(%8 8(% 4 6_ (8* (! \()( (! !!)% 67_ 6_
!0()( >E_ "!#$%&! (/%*(% AE_ (U(% 46_ (! ,( 5'
=:82 / ' )'%&! "$!O $ *($% (! * ) $M/%&!D $M (! !)
$ (!Q "$! #( 7J_ /%&! )! !)D $M! $ ) (D !
(8 ! *@%// : (*% $8 76EJ "( ('(% * $$D 5' =:8 &!% :
&! 2A_ ) (* ' ) <(" % "('% $ !'! '($%0D !) //*! /%&! )! !) ! 1461 *(*!Q "( %( * $$D 5=8 ( ' &! $( "8($* )
J M( '% 8%)* ) /(Z %0%/%*(%8 &! *@U *!Q &!% "(% !
(* ' ) (" % *@U $ '($() "( )M(! ," ) *(* *(* ) $(
" ( %*$! $( "8($* )! J (% 0$%0(#$ 5:82 /%&! )! )
(""$ &!M%$ M(0% )! (* ' ) (" % ! " ) $( / ' (/%*(%
)'%&!D
<969>9 # @+% C P B'+ C%,,+' #"%+(/'
766> $( '($()% ) <(" % (% $ *%&!%:' ) *(* &!% !8! *@U $
*8! )M($$ 0// )M 0( 5=:82 // )M(": $ (8(!Q ) '( * $$D 5<>8
*@U * '($() $ *(* )8$ "" "! ) '" (! )#! ) $(
@("!%&! T )( >_ ) *( )( 14_ ) *( %$ M(0%(% ) (* ' )
(" %D "$! ! &! * (* ' "$! #8 *@U $ ("$( &!
)( $( " "!$(% 0($ 5782
&! $M(0 %''! !""! $%'% $ $% ) (* ' ) (" %
0 "!8 'W' )%"((. * '"$:'
5782 ) 0!
%''! )"%8 0($ ( *% (! (* ' ) (" % )
* %* +) !%$% *@U $ ("$( )M 0(D (* ' ) (" % "!
(!% W #8 *@U $ ("$( )M 0( !%$%( S )M(! /% *
* %* +) (**$( $( " 0% )! (* ' ) (" % *@U $ !3 %)D
M(! (0 %''! !""! $ &! $M(U(@% "% $ *,*$ " % "!8
W ( *% (! (* ' ) (" % '(% S ! (!Q %* ! 57.,82
<96979
# @+% C P '@A"+' P (* ' ) (" % "$! /&! *@U $ !3 %) &! )( $( " "!$(% 0($D
!) ' &! $ (* ' ) (" % 8% 422 / % "$! !8
*@U $ %) &! *@U $( " "!$(% 0($ * (* ' ) (" % ( *% (!
122 / % "$! $8 &! *$!% !8 *@U $ %''! )"%' $% S !
% $ 0% (! &! $ K"( Q'"$ %''! )"% %( 0:L 5?3>682
/%&! $M%*%)* )! (* ' ) (" % (! * ! )! 8(%'#$(#$' !%' )! /(% ) $( #:8 !8% ) "(% (": $M(""(%% ) "'%: '(%/(% "" !%D %% ( "8($* /(%#$ )( $( "$!"(
) "(, (/%*(% A S >_ $ $ % @ '% $M/%&! *($ ` $$ "! (%)
3!&!MS A7_ ) %) N('#% 5=:82
4>
0 $ /(! *")( !$%0 &! #% &! $ / ' ) (* ' ) (" % )%//
! $ "$( *$%%&! "%)'% $ 0%&! ! $ $% #8 (! * ! )! (* '
) <(" % @% %&!' %'%$(%D ( !'! * '" ) '!$%"$ ," )
*$$!$ (""$ B *$$!$ /!(!Q C &!% "((% (8 % !
%0%
'*@,'(! ! ) @$%($ 5<>82
8%! )* )( $ *$$!$ ' !*$ (0!% ) !3 (% )
(* ' ) (" % $( "* )! 8%! )( * *$$!$ (8( $( !8! )!
(* ' ) (" % ")%*%8 ) $( !8! ) * '($()% 56:82
\%*< * $$D 5<=8 !)%: 4227 $M( *%(% $ (* ' ) (" %
! $ J $M K
'%( '"$QL ! ! " "!$(% ) E66 @ ' Q!$
%/* (! D $ (%8: S $( * *$!% &! $ (* ' ) (" % ! $ J M(
"( )M%/$!* %0%/%*(%8 ! $ %&! ) )8$ ""' ) $M )( ! 0 !"
(8* ! %&! !%/ ' ) )8$ "" $ (* ' ) (" %D
<9?9IC+ B"
',$ ' '!$%"$ &!% " 8% 7_ ) *(* (* ! "$(%
'($%0 (//*( ! *$$!$ "$(' *,(% %''(! ) $( ' $$ ! " )!*%*
)H! %''! 0$ #!$% ' *$ ($D
M&!%" ) (($$% ($% ( !"* $ J * '' /(*! % $ 0%&! )!
',$ ' '!$%"$ 5<G82 // $$ ( "! ' 8%)* $( "* )! J )(
$ *!$! ) "$!%! '(% ) *$$!$ ))%%&! '($ ')!$$(% K>J^
J1^L *@U ! $ "(% (% ) ',$ ' '!$%"$ *@U ! "(% )
"(% (% ) 0(''("(@% ' *$ ($ ) %0%/%*(% %* ! K
L ($ &!H%$ (% %)*$(#$ )( $ ("%(% ')!$$(% (! ' ' ) $( '% *!$!
5>8
": ! (($, &!(%(%8 )! J Q"% 0%&! *@U )
"(% *@% % (% ) ',$ ' '!$%"$ 0 F * $$D ' &!M%$ Q% ! $%
$( "(@ 0% )! ',$ ' '!$%"$ $M%/*% S JD !$( #! (": (($, &!(%(%8 )! J Q"% 0%&! *@U )
"(% *@% % (% ) ,$ ' !$%"$ 56H?82 !) ) ( * $$D 5?<8 ' ! $% $ 0%&! ) J *@U $ "(% (% ) 0(''("(@%
' *$ ($ S %0%/%*(% %)'% K
L ( " 0% 8 $ ',$ '
'!$%"$ )( J7_ ) *( !%$%( $( '@ ) )H%''! #$ ) (%0: D $$ * *$!% /(% $M #3 ) * 8 "$!%! *@*@! * '' $#$(@%
* $$D 568 M(% "( * 8(%*! )! O$ 8%) ) J )( $( " 0% )
('' "(@% ' *$ ($ S %0%/%*(% %)'% 8 $ ',$ ' '!$%"$D
8( $M%'" %#%$% ) )* $ 8%! )%*' )( $ ("%(% ')!$$(% * &!% /(%(% 8%(0 ! (/(* )a S $( *!$! ) "$:8' $M&!%"
('%*(% ) ( *@*@ $ 8%! )( $ #% "% ! )( $&!$$
$M'#$ ) *$$!$ '($ ')!$$(% "582
( )* "( @,#%)(% % %! )( 4 S 72 _ ) *$$!$ *@U 7G;42
"(% ',$ '(!Q * 2;47 "(% !//( ) $,'"@ ' $!*'% 2;A
4G
!3 ( '(!QD
! $ 8%! (% (# *@U 1 "(% ) $( " (! (%' (%
* '"$:D @U $H! )H !Q M(% "( )*$(#$ (": 0// ($ &!H%$ $M(%
(8( (%'D )% !$( * )!% S " &! $ 8%! J " !(% 3 ! !
O$ ! (! $ 0 ) $M8 $!% *$%%&! )! ',$ ' '!$%"$5>82
&!%" /(Z(% ( * /%' "(% * !$( !8( $ 8%! )(
7J;42 #% "% ! ) "(% ',$ '(!Q * 2;42 #% "% ! )
!3 !//( )H(! (//*% '($%0 ! ( "*%% ! $( (! $
" !*(0 ) *$$!$ %/* % ! $ () *$%%&! ) "(%568
")( "$!%! &!%" * $ !$( ) $M&!%" ) %8% S * %) $M@," @: )! J )( $ ',$ ' '!$%"$ (8* "!)* (
! $( #( )H(0!' "%)'% $ 0%&! &! )8( $( )%//%*!$ ) " )!% $
!$( %%%(!Q 5>H382
<9>9## #,"#'
( '($()% ) ($'( ! (% )! %! $,'"@ +) ( *%( ) $% )H@,""$(% (0% / $$%*!$(% ! (#$(! *$%%&! !%( /%:8 () "(@%
"$ '0($%D $$ /&!'' #8 *@U $ !3 (% ) (* ' )
(" % 5>682
( '($()% ) ($'( '!$%*($ ! ," "(%*!$% ) ) )
$,'"@ " $%/(%/ ( *% (!Q ,'"O' %/$('''( % S $( ),0!$(% ) $M>D
( $ * Q ) $H%/*% S $( '($()% ) ($'( ( *% S $H%/*% S
JD
/(%#$ "* )! J ( (": ! !) /(% ! ) "(%
3(" (% 0(%/ (% ) $( '($()% ) ($'( 5GH82
!% ! *@(0 8%($ $8 ( "! W )* *@U ) "(% " %%/
"( 'W' '" $( '($()% ) ($'( 5=82
) * /%' "( ! (! !) &!% (#$%(% ! )%%*% $ ," "$(' *,(% K*((*% "( ! " $,() "(@% * " )( S $(
)/%%% *$(%&!L $ ," @,($% 8(*!$(% K*((*% "( ! %/%$(% "!) !' ($ )! ')%(% ! ) $H"(* "% ($L $( '($()% ) ($'(D
J (% ( *% !%&!' (! "'% ,"D $ ( 0($' !8
)( $ *$$!$ ' !*$ (0!% (! * ! ) $( '($()% ) ($'(
5>H3::3<G8
<979
, I-+, @@B, , ,C%B,,2
J ( *'' )* )( ) *( ) $,'"@ ' )%//! ) ! K !
" ! & !
'& L &!% ! ) ( $,'"@ ' ) *$$!$
/&!'' ( *% (! D
4J
0 ( ! !) ' "( (% * $$D (* ! ! % ) 4E2 *$$!$
" 8( ) "(% (,( ! *(* $,'"@ " $%/(%/ K414 ( *% (!
7J ( *% (! L $ &!* )H )! J )*$ !$'
*@U 1 "(%D 4 "(% &!% (% ) @ ' Q!$ " %%/ )"!% 76JE !//(% 0($' ) K$H! (,( ! !'! "$!($ $H(! ! !'!
"% ($L (8(% ! (!Q )H $8D
(%' (!Q (! *@U $ %%:' "(% &!% (8(% ! $,'"@ '
%''! #$(%&! ( *% (! $ %8(! ) &!* )! J (% (U #(D
@U $ )!Q "(% $ *$$!$ *$ ($ %/* "( $ J (%
%''(! (8* ! "@ ," )'% (!% %/* "( $M 5>H82
!) ( 0($' )' &! $ &!* )H ) J (%
#(!* !" "$! /&! )( $ *$$!$ !' ($ )( $ #% "% *!( )
(* ' ) (" % ()% &!M(!*! &!* )M ) J M( )* )( $
$,'"@ *, )! (0 "%"@%&!D
!$( ) * !) 0($' ("" &! $( ( *% (! J
(% /&!'' * ! " *@U $ "(% %) * /%' $(
*@(0 8%($ $8 )! J )( $ *$$!$ !' ($ ) * *(*D
")( $ J '#$ "( 3 ! ! O$ "(@ 0%&! )( ) "$(%
$,'"@ +) '($%0 ) *$$!$ ! D
&!% / ' * "( )H(! *@*@! K('( * $$DL &!%
!% &! $ J "(%*%" / ' (! )8$ ""' ) $( &!M%$ !
8%! (/ '( )( ! 0 !" ) 8%! Q*"% $ ( *% (! $,'"@ ' "$!
56>82
9 N 4 ! "$( #% $ 0%&! $ )%(0 %* ) $H%/*% S J * '") )!Q 8 $ - !
)%(0 %* )%* &!% '( 8%)* ! ! ! "(% )! 8%! ! )%(0 %*
%)%* ` $M '( 8%)* $ (%* " "*%/%&!D
969#('+,"A %A"
96969%C/E'"
J )* )( $ $% %!$(% ) '($() (% ) (* ' )
(" % ) $,'"@ ' )%//! ) ! ) $( '($()% ) ($'(D 8%! 0($' !8 )( $ %! (% ) * '($()D
8%! ( !8 )( $ $,'"@ *, 76 " %%/ *MS)% $
46
$,'"@ *, "( )( $ $,'"@ *, J " %%/D 8%! (' !8
)( $( ($%8D ! $ "' $ !$( * ()%* % - )( ! *( $ 8%! (# T )( ! (! "!#$%*(% %$ !8 )( 67_ ) *@(%$$ 8( )
!3 @ ' Q!$ " %%/ 41_ ) *@(%$$ 8( ) !3 ' % 53?=82
969?9
# B"B%
$$ " %#$ '(% $$ H "( !%$% " ! $ )%(0 %*D 5?<3>73=?3<73<:3<<8
969>9
N#@A#"+' (C'DB +B ( ! '@ ) ) )*% )%* )! 0 ' )! 8%! T *H ! '@ )
(""$%*(#$ (!Q #% "% %!$(% (!Q $%&!%) #% $ 0%&! K($%8 "'DDDL ( !%$% " ! $( "'%: / % "( @(0 * $$D 766A5>G3H82
( *$(%&!
( 0% )! 0 ' &!% ( ('"$%/% $( 0% 7 &!% "'( (!% )
($% $ 0 ,"(0 )! 8%! #( ) $M"%)'% $ 0% ' $*!$(%D
": $H('"$%/%*(% 0%&! $ /(0' 7 *$ S $H(%) )H! "$('%) )H!
#(*% K%
LD " )!% ) *$ (0 !% !)% "( &!Z(0 57782
( '" $
( ! !8$$ '@ ) " ! $( &!(%/%*(% ) $M )! J )(
$ "*%' *$%%&! )( $ *$$!$ ' !*$ )! (0 "%"@%&! 0($' )( $ #% "% )! (* ' ) (" % 5>782 $ M(0% )M! *@%&! ) &!% / *($% ! $( "@( Q" %$$ ) $( (*% D
9?9#('+,"A ' %A"
*@*@( $ (%* " (%(%0: $,%&! ! (%D
! $ "'% ! %''! U,'(%&! 8 $ % !%$% $M(%0:
(*%/ ! " % * '#%( "7J " ! %'" * $$D "A2 " ! %$$ * $$D
5=H82
! $ * ) $M(%0: ! " % !*$(% ( *% S $( $(* 8%($ $ !%$% $ "$! !8 ! %''! /$! ** %)%* T 57?378 $M%''! #$ ( !%$% (%% &! $ \#$ 5?<37?82
9>9'"%%C"#"+' , %C,B"#",
$ 0%&! "$! %#$ &! $M('"$%/%*(% 0%&! //*! ! $
*$$!$ (0!% ' !*$ 5?<8D * '"(( $ 4 $ 0%&! %$ (": $ !$( ) * $$ 5:H82 &! $M%''! /$! ** K*@*@ )
(%L ) (% "( ) " " %%8 *@U $ !3 S /(%#$ %&! K" "!$(% 0($L ($ &! $M (8(% ! " (%* " $,%&!D
12
0 ($(# * $$D 8(*@ !8(% $M%''! /$! ** : %#$ "*%/%&! 56=82
G9 $
(* ' ) (" % ( ! ) "%*%"($ *(! ) ' ($% *@U $ %)
( *%(% (8* $M%/*% S J ( '(%( (#$% ! (%' (%8%($
M(8: W ! *% 8 % ! !0* " ! $ *@*@!D
(% ) ' %0 )M! 0% ) $% ! ! ($%' )
$( "$%*(% )! 8%! ! "@ "@ / '( 5>?3G:3G82
M&!%" ) %&! D ( )' &! $ "@ "@ / '( ! %@%#%!
"*%/%&! ) $M " $,'( ) "8%! &! // @("!%&! #/%&!
)( $ (//*% (* ' ) (" % "! W %'" (D
$ "! W ! %@%#%! ) $( ('%% ) $M ) J )( $ $,'"@ '
)%//! ) ! 5:G82
!) ('%*(% " "*%8 ! ) !3 " %%/ (! /(% ( )M!
)%'%!% %0%/%*(%8 )! %&! ) (* ' ) (" % (8* ! (%' "( $
"@ "@ / '( ($ &! $M(*,*$ 0!( % M( (!*! // ! * %&! 5=<82
")( ! &!%" /(Z(% (8(%$$( ! ! " "!$(% * '"((#$ M( "(
!8 * // )! "@ "@ / '(D
!) ( /(% (!% ! $M%'"(* )M! ' $*!$ &!% $ $%" '($
) Q !#%*% ! $ J *@U ) "(% " %%/ (! (8* $ (* ' )
(" %D
)%'%!% %0%/%*(%8 ) $( 8%'% S J ( * ( "( $M&!%" )
(%( !U ")( $ (%' (8* $( )% ' $*!$ #% &!M%$ M, (% "( ! )
* $(% $( " *$%%&! $( *$(%(* S JD
M!%$%(% ) ($*($ +) ) $( 8%*( 0($' "* % - $( %#$(% $(
%*%% 5G82
M(*%) % +&! ( ! // %@%#%! ! $M> &!% "! (. ! " $%/(% )
*$$!$ %/* "( $ J "( ! "@ ': )M(! 0!$(% D 'W' (*%)
% +&! ( ! // (%" $%/(%/ ! $ $%0 *$$!$(% %/* "( $ 8%!D
!% $M!%$%(% ) B %0@$, *%8 % 8%($ @("% C KL (8*
%@%#%! ) $( " ( )! * '' $M%)%(8% $ (&!%(8% )( $ (//*% (* ' ) (" % "! W : %'" ( )( $ (%' ) $M%/*% (!
J 5=<82
"" *@ @ ' ($ $!%! !)
' &! $M%/*% S J (% "$! /&! *@U $
17
@ '' &! *@U $ /''D *% )' "( 9%0 * $$D 766E 5G>3G8 &!%
" !8 $MQ%* )M! /(*! )( $ !% ) /'' *% &!% #$ &! $(
* %(* ) $%0 *$$!$(% )! 8%! JD /(*! (% $ K!'(
@ % %* () "%LD
(%' ) $M%/*% S J "! 0($' !%$% $ ()%(% T '(% %*% $
!$( "(%$ $ // * )(% 0$%0(#$D
M! '(%: 0($ "! !%$% $ (%' $ *($ $ (%' (8* $
%/ ($"@( KL ! (8* $ (0 *@%'%&! Q%&!D
@("% $ *($ !%$% $ ()%(% $( *, @("% $ %/*% %($% $$ $ (""$%*(% ) ) 0! 8(%D
(% $( @("% ) $M%/*% S J /&!'' $%'% "( ! ! "%
5G82
* &!% * * $( "8% * (%( $ )%// ' )($% )
('%% )! 8%! $( "8% ) $M%/*% S J "( #$%0( %' "( V
$ )"%(0 ) " S %&! S (8 % $ " %! $ @ ' Q!$
V
$ )"%(0 ,'(%&! ) ) ! ) (0D
V
"% *@(0 ) " " %%8 (! J " !(% "' )
'%!Q !8%$$ $M8 $!% $( " "(0(% ) $( '($()%D
6H2
Q #3*%/ ) * !) $ !%8( -
14
V
'% $( "8($* ) $M%/*% S J *@U $ !3 ) 2 S 42 (
* !$( )( 4 (#$%' ) ( "!#$%* S (<(D
V
'% $ "(%*!$(% ) $M%/*% *@U $ /( /(%( $( * $(% "8($* "((': "%)'% $ 0%&!D
1 2 1 2 62 9 %C,'"#"+' -"# 2 M@O"%($ %%) $ )"!% $( / ' ) 766J ! @O"%($ ) %8(! 1
K@O"%($ (% ($LD $ ( ! *("(*% ) GE2 $% //*%/ K7222 $% @ %&!LD "$! %$
* %! ! @(! $%! ) / '(% " ! $ !)%( )*% @('(*%
) '( $ 0% (!% " ! $ $:8 ) * $ "((')%*($ K%/%'%
(0/'' )M( *@%*% ) $(# ( %LD M $M! ) !*! @ "%($%: $
"$! %'" ( ) $( ! 0% D
, !8 )%// 8%* *$%%&! ) )*% ) "*%($% )%*($ )
@%!0% "*%($% *@%!0%*($ '(% (!% $ 8%* * ''! K$(# ( % 8%* ) ()% $ 0%L ) $ $(# ( % ) (*% $ 0%% $ 0% *() ) !)D
? 9 #.+%#"+% &#A"C%++(9%++(
$(# ( % ! 8%* @ "%($ !%8%(% &!% ( " ! 8 *(% $ )%(0 %*
#% $ 0%&! ) %/*% #(*% 8%($ $( *@*@ $( / '(% )( $
11
) '(% ) $( (*% $ 0% ) $( % $ 0%D M ! * ) /* '(%:
)M%/*% D Q!$$' ('%%#$ ! * * $$(# (! ;
D M@O"%($
%%) (* %:0 )! (! /%*(% ) *@*@ ! $ %)( K/%&! ) $M!
)! L $ $(# ( % (#% (!% $M #8( % ) %(* (!Q (% 8%(!Q
$ " 0('' ) *@*@ ! $ 8(**% (% /%&!D
" 0('' ) *@*@ 0 "( ! &!%" * %! ) V
" $ ')%*($
P
74 "@('(*% #% $ 0% ) 1 " /! )M!%8% "('% $&!$ $ *@/
) 8%* 4 (%( ) /(*!$ 7 #% $ 0% ) @O"%(!Q > %
P
7 ')*%#% $ 0% 1 ')*% *$%%*%
V
" $ *@%&! P
*@%*% !"%! *@%*% (%) *@%&! %/%'%: )M( 0(Z /%$$ ) $(# ( %
P
" $ ) '(%(* " ! $M% ) $M&!%"'D
'' $ ' $M 0(%0('' ) $( "(0 *%(": * $(# ( % * '")
"%*%"($' % !% - $M!% ) (*% $ 0% $M!% )M''! $ 0%
$ 0% $M!% ) % $ 0% $*!$(%D ! ($$ " ! ) (% "(%&! "
!%&!' $ *% )( $&!$$ ! (8 (8(%$$ V
(**!%$
V
!% ) #(*% $ 0%
V
!% ) %$%(% V
!% )M%''! $ 0%
V
!% ) #% $ 0% ' $*!$(%
?9 69 #AAB
, !8 ! 0!%*@ ! #!(! ) "$(*() ` (0 $ /!%$$ ) (8(%$
$ /!%$$ ) B $%%0 C ! )%(! &!% / *% (! (8* $ (!
)%(! ) $M% ) (*% $ 0%D
M S * %8(! &! M(#$% $ "'% * (* (8* $ '($() - %$ , !8( $
%0' ! $ (($, $ * )%% )M(($, $( (%/%*(% D "(% 0% (8* ! !' ) * ) '(!$$' K$%%0L ! $M )%(! K/%*@%
B **!%$ CLD $ *($ (!% ) *(%( *( , '"$% $ /!%$$ ) (8(%$ " !
$ )%// (($, S //*!D , )$%8 $ !$( ! "$% /' (!Q '($()
Q T $ (0 ) 8%* *$%%&! 8% , *@*@ $ !$( ) "(%
@ "%($%D
1A
1 2 ": $M&!W $ '($() "(% (! %8(! ) $( ($$ )M( (8( )MW Z!
(! %8(! ) $( ($$ ) "$:8'D
( ($$ ) "$:8' * '") 1 # Q - ! "'% ` $M //*! $
"$:8' ) (0 )!Q (! * %0! '!% )M! /W ) ( )%*'
! $ $(# ( % ) (*% $ 0% ` ($% ! $ (! "$:8' S
$MQ*"% ) $$ ) !% " ! $&!$ ) %$ %! )( $( * ! )!
8%* "*%($' * Z!D
? R ? B'"C &#A"C%++(
$ )%8% "$!%! "(%$$( )% (! (%' ) ! $ " )!%
"(@ $ 0%&!D ! (8 $( "(%$$( ) "$:8' 0%(!Q *$$ ) $MQ('
*, #(*% $ 0%&! ) !% KL $( "(%$$( ) $%&!%) *"@($ (*@%)% )
$$ ) @' *!$! *$$ ) B %8 C ` /(% $ (%' ) ! $
(! " )!% "(@ $ 0%&! K"! (*% $%&!%) )M"(*@' Q"* (% cL /% $( "(%$$( ) (%#% 0('' &!% "' ) $( %#%$% (!Q (%#% %&!
) ! $ !*@ #(*% % $ %)%/%D
? R > # ,# ,"C%,#"+'
M ! !% %* !(#$D * %8(! M//*! V
$( ""((% ) '%$%!Q ) *!$! ) (*%/ $! * )%% ' $!
%$%(% T
V
$( )* ('%(% )! '(%$ ) " )!% #% $ 0%&! (8( $! *!"(% !
$%'%(% $ $ *(D
V
$ ,(0 )! '(%$ (8( $ *,*$(0D
? R 7 B'"C B'++(9C%++(
M $M!% ) )%(0 %* ) $M%/*% S "%*%"($'D (% , //*! (!%
)M(! $ 0% 8%($ K"(% !# $ , '0($ 8%! *cDL
$M%''! $ 0% *$$!$(% (8* $( )'%(% ) (!Q ) A J " ! * &!%
! * * $( $ 0% #(*% ('' $( $ 0% ) !
$( $ 0% ) $( ,"@%$% K LD
1E
1>
0 3 0 3 69+B#"+' C"B 6262 %C/E'"
! (8 * $$* $ "$:8' ) !3 R0 ) 242 ( ( )%%*% )
QD "$:8' (% (*@'% 8 $ $(# ( % ) % $ 0% ) $M@O"%($
$# , ) ( $ $(# ( % ) % *@%'% ) (*% $ 0%% $ 0% )
$M(#$%' !#$%* ) ( D (* " ! $ '($() @ "%($% )"!% $
8%* ` %$ (% % (! %8(! ) !*! @ "%($%: ! //*! !
"$(* " ! $ "(% QD
! (8 0($' *!%$$% $ !$( ) (($, #% $ 0%&! " ! !)%
! 8!$$ * $(% * "((': $( $ 0% JD
%% ! (8 *!%$$% $ !$( ) (($, #% $ 0%&! //*! "( $
"(% 1G
1J
V
1E "(% 8! %%%($' " ! $( )'%(% ) $( #%$%!#%'% ($
V
%$%!#%'% %)%*
V
%$%!#%'% )%*
V
@ $ $'% ($
V
(%%'%
V
(0'%
V
) "@ "@(( ($*($%
V
"@ "@ '%
V
1 %&!
V
$ 0% V
$ 0% V
0$,*'%
V
*($*'%
V
" %)'%
V
!%*'%
V
41 V
4A V
9%)($
V
$
V
V
$ 0% @$(',)%(
V
$ 0% Q "$(' V
%0$,*%)
V
($#!'%'%
V
('%
V
('%
V
V
V
@
V
$ #!$ !0
V
$ #!$ $(*
V
)M@' 0$ #%
V
)M@'( *%
V
$(&!
V
77A )M''$
0 3 )%// "$:8' ($% !# * ! (8* (%* (0!$( $ $(
! $ (($, KL %%%($ KL $ !' ! $ "$('( * " )( ( #! (":
*%/!0(% !% * 8 P425D
?9 #"C% " %C#A"@,
?969 #"C%
'(%$ * '" %$$' ) V
%" '!$%*((!Q 0$(#$
V
%* "%" 0$(#$ K72 42 722L
V
'# ! 3(!
V
%" )%%#!%* ^ '# ! K'!$%" ^ * '#%%"L
V
$(* *< ) E22 7222 '%$$%$%
V
% ) 4E2 74E '%$$%$%
V
$((!Q " ! $('
V
('$$ * !8 #3 K4AQE2''L
V
8 % " ! $( )%%#!% ) (*%/
V
'" S 8%)
V
(* S )*@
V
!8 S 1G5 V
@('# @!'%)
V
(* ) * $ (% V
0%(! " ! #(* ) * $ (% K(0%(! %)%'% $L
V
(@% ) "(%$$(
V
. ) (0' * 8(% ) $('
V
%* * " S /$! **
V
(, "("% 4
V
(&!! %)$#%$
V
("% ($!'%%!'
V
("% #!8()
V
(
V
(* " !#$$ (! *$(8(#$D
V
16
V
?9?9C#A"@,
! (8 !%$% $ <% J 0 ) $(# ( % B 8(* % *@ $ 0%
* " () C K /D 7E112222L &!% * '") V
(' S 72 "!% ! $&!$ ("" ) *$$!$ %/* "( $ JD
": ("" %% $ $(' /%Q S $M(* S ^A5D
V
!' ) * O$ 0(%/
V
!' ) * O$ " %%/ - * ( ) (%* " 0 (% J #! S "(% )
!3 (% ) (* ' ) (" %D
V
%* " 0 * 3!0! (8* $ V
$!% ) ' (0 - 0$,*% ('" V
$!% ) $(8(0
V
(! )%%$$ %$
V
>9C"-+ ,
>96 C%++( ! * *@*@ ! (8 !%$% $ <% J 0 ) &!% ! " *) )
'% 8%)* ) $( /(*% 0 ) (%* " (%!'( "8%! ," J "(
%''! /$! ** %)%* KLD
>96969 %'A B ","
" *) * % S //*! )!Q "@( -
A2
V
( $( "'%: "@( $ !' S '% * (* (8* ) *$$!$
%/* "( JD $ M(0% ) *$$!$ ) $( $%0 7 " 8( )M! $,'"@ '
) *(8% )M! !3 0(%/D % $$' 12 _ ) *$$!$ %/* (3 ! " ! * %! ! * O$ % ) (*% D (%* "
'% 8%)* *!Q )%%0 * $ (%0: $(D % $ !' * %
) (%* " K*L "*%/%&! ) J %$ , ( / '(% ) * '"$Q
(%0:(%* " K0*LD
VV
% $ !' * % "( )M(%* " "*%/%&! ) J %$ M, (!( "( / '(% ) * '"$Q ! $ * '" ( )! !' (. )( $ $%&!%) )
$(8(0D
0 3 V
( $( * ) "@( (3 ! ! (%* " (%%''! 0$ #!$% @!'(%
* 3!0! S $( /$! **D ( "* )M(%* " (%J K(*% " %%8L ()!%( "( ! /$! ** 8" '' (! '%* * " S /$! **D
V
% $M(%* " *@*@ " K(*% " %%8L #% ! /%Q(% ) *
(%* " /$! * ! $ * '"$Q 0* )3S / ' (!( ! /$! **
8 &!% ( #8 S $M(%) ) '%* * " S /$! **D
V
>969?9 A-'DB
# %C#%#"+' , ,C%B,
!' )M(# ) )%$! (! 7;A2 )( )! $8( ) $(8(0 * %!D
42d$ ) !' ) * O$ " %%/ "$(* )( $ "!% 5 7 ) $( $(' &!% * '" 72D
42d$ ) !' ) * O$ 0(%/ "$(* )( $ "!% 5 4 42d$ ) $( $!% ) $(8(0 )( $ "!% 1D
!' S )%%#! )( $ "!% ( S (% )M! !' "(
"!%D
$(' (0 )( ! *@('# @!'%) &!% * !8 (8*
)$%*(D
M%*!#(% /(% S 1G5 ")( 12 '%!D
! # ! ) 12 '%! )M%*!#(% " *:) (! $(8(0 ) $(' )M(# ) "(
! %Z(0 ) !Q S $M(%) )M! "% T "!% $ $(' "$ 0 )( ! #(* )
* $ (% * ( )! $%&!%) $(8(0 )" ! ! (0%(! %)%'% $ ")(
E S 72 '%!D
": * "@( ) $(8(0 $ $(' % )! #(* ) * $ (% $!
!/(* *@ )$%*(' "( ("%(% )! !"$! ) $%&!%) S $M(%) ) $( " '"
S 8%)D
( )!Q%:' "@( ) $( (*% $( )%%#!% ) 42d$ ) * 3!0! (% 0
@!'(% "( "!%D
)!Q (" !%8( K%*!#(% $(8(0L %)%&! S *$$ ) $(
"'%: "@(D
! $M #8(% '%* * "%&! 72d$ ) $%&!%) ) ' (0 (3 ! S *@(&!
"!% T $ $(' ($ * !8 )M! $('$$ $ B *%0 C /(% (8*
$M #3*%/ 7>2Q
% $( $*! ) % W )%// $( $(' ' "$(* *@('# @!'%) S ^A5D
>969>9 '"%%C"#"+' , %C,B"#",
A7
' % " %%/ J )8( ' ! /$! ** 8 " '' )%//! ! $%'%
) *$$!$ %/*D *$$!$ %/* )! 'W' "!% )8$ "" !
* $ (% !0 (0D $ ( ) 'W' " ! $ * O$ 0(%/ $ #$(*D
>9?9 L+"#"+' , %C,B"#",
$ 0%*%$ %$ (< AD2 ( "'% $( 0% ) ) *(% S $MQ"$ %(% ) !$(D
Q"$ %(% ( ($% S $M(%) ) $ 0%*%$ 8% 72D2
>DAD
K
(%%*($ (*<(0 / @ *%($ *%*L "% %/ 8% 4222 "%(#$ 8% ! $( * '"((% ) " " % $ )! e ( !%$% (8* ! %8($$ )
* /%(* ) 6E_ *M S )% &! $( )%//* (%%&!' %0%/%*(%8 % $( 8($!
) " (% %/%! S 22ED
* $(% /(% "( $ *($*!$ )! )) (% S ! %8($$ ) * /%(* )
6E_ $ $( / '!$ * %0 T /(*! ) %&! J (% $% % )) (%
!"%! ! 0($ S 7 (8* ! 8($! ) " %/%! S 22ED
A4
4 0 4 0 69
M!) ( " ! 1>6 !3 ) 2 S 42 ( " 8( ) 4 !*! @ "%($%:D
6969C#%""+' # +B#"+' C"B ,+' +%(' B
%C/E'"2
#.#B 0 C#%""+' # +B#"+' C"B ,+' +%(' B %C/E'" 0
O"%($
(*
$# ,
($
'#
7>J
427
126
_
AEDE
EADE
722D2
69?9C#%""+' # +B#"+' C"B ,+' S(2
A1
#.#B 0 C#%""+' # +B#"+' C"B ,+' S(
0
2E (
>72 (
777E (
7>42 (
'#
6E
66
722
GE
1>6
_
4EDG
4>DJ
4GD7
42D1
722D2
/( "(% A 0 !" ) (%$$ $(%8' 8 %%D
62> C#%""+' # +B#"+' C"B ,+' +%(' -+,"#/% "
S(
#.#B 0 C#%""+' # +B#"+' C"B ,+' +%(' -+,"#/% " S(
O"%($
0
(' >72 (
777E (
7>42 (
(*
#
>
A2
AG
GE
7>J
_
1DJ
41DJ
4JD2
AA>
722D2
#
J6
E6
E1
2
427
_
AAD1
461
4>DA
2D2
722D2
!3 ) 27E ( /! '(3 %(%' *! S $# ,
7>42 ( /! Q*$!%8' *! S (*
6979C#%""+' # +B#"+' C"B ,+' ,L
#.#B 0 C#%""+' # +B#"+' C"B ,+' ,L
Q
'%%
'#
42A
7>E
1>6
_
EED1
AADG
722D2
!3 ) Q '(*!$% "$! '#!Q EE1 _ " ! AAG _ ) !3 )
Q /'%%D
69:9 C#%""+' # +B#"+' C"B ,+' -+,"#,#"+'
#.#B 1 0 C#%""+' # +B#"+' C"B ,+' ""% '"%' +B L"%'
AA
4 0 "%($%(% '#
41A
71E
1>6
_
>1DA
1>D>
722D2
( '(3 % ) !3 (% @ "%($% (8* 41A *( % >1A _D
69=9 C#%""+' # +B#"+' C"B ,+' B %C, 'A
#.#B 1 0 C#%""+' # +B#"+' C"B ,+' B %C, 'A
)
) *
*
(<(
(% !%
!0(
% !#$
@%:
(('(*
( $(*<(%*<
'#
E6
4E4
6
G
42
71
1
>
1>6
_
7>
>JD4
4DA
7D6
EDA
1DE
7D>
7D>
722
'" ! )! $%! ) %)* S (<( ) $( '(3 % ) "(% *!
! (8 * %) " "!$(% )M!) "( ("" S (<(D
69<9 C#%""+' # +B#"+' C"B ,+' B %C, 'A P
#T#%
#.#B 1 0 C#%""+' # +B#"+' C"B ,+' B %C, 'A P #T#%
)
I!(% " "!$(%
I!(% %)%$
I!(% !#(%
'#
412
>
7>
4E4
_
671
4DA
>D1
722D2
"(% $(0' %! ) &!(% " "!$(%D
699 C#%""+' # +B#"+' C"B ,+' # %+@,,+' B /%
#.#B 1 0 C#%""+' # +B#"+' C"B ,+' # %+@,,+' B /%
AE
/% "*%
( '"$ %
!$%8(!
*(%*%'!%%
!%%%8)!
(%
0 )M()'%%(% 0 )M"%
()
''Z(
'%0
'#
64
1A
1>
E6
6
42
7>
44
77
16
7
1>6
_
4AD6
6D4
6DJ
7>D2
4DA
EDA
AD1
>D2
1D2
72D>
EDG
722D2
$(0 0('' ) " /% ( !8 ($$( ) *() (!Q
(" /% D
'"! ) $( / " " % ) !3 ) $( " /% )! ": "*% ! ($$ * %) " "!$(% )M!) "( ("" S *!Q ) $(
" /% ) ": * !D
#.#B 1 0 C#%""+' # +B#"+' C"B ,+' # %+@,,+' B /% A+''B
/% ( '"$ %
!$%8(!
*(%*%'!%%
!%%%8)!
(%
0 )M()'%%(% 0 )M"%
()
''Z(
'%0
'#
1A
1>
E6
6
42
7>
44
77
16
7
4GG
_
74DJ
71D2
47D1
1D4
G4
EDJ
JD2
AD2
7AD7
2D1
722D2
'' $ ' $ (#$(! $ !8% 8% W !%8% ) * ''Z( ) *!$%8(!
69G9C#%""+' # +B#"+' C"B ,+' # %+@,,+' #
/%
#.#B 1 0 C#%""+' # +B#"+' C"B ,+' # %+@,,+' # /%
A>
4 0 /% "*%
( '"$ %;'(0:
!$%8(%*
%(
)!
!8%:
'%0
0 )M()'%%(% 0 )M"%
()
''Z(
'#
J>
44G
6
A
77
4
4
G
E
4
7A
1>6
_
41D1
>7DE
4DA
7D7
1D2
2DE
2DE
7D6
7DA
2DE
1DJ
722D2
#.#B 1 0 C#%""+' # +B#"+' C"B ,+' # %+@,,+' A+''B # /%
/% ( '"$ %;'(0:
!$%8(%*
%(
)!
!8%:
'%0
0 )M()'%%(% 0 )M"%
()
''Z(
'#
44G
6
A
77
4
4
G
E
4
7A
4J1
_
J2D4
1D4
7DA
1D6
2DG
2DG
4DE
7DJ
2DG
AD6
722D2
/( ) ': ( '"$ % ! '(0: * %! $( '(3 % ) "(%
KJ2D4_LD
696H9C#%""+' # +B#"+' C"B ,+' #('+,"A
#.#B 1 0 C#%""+' # +B#"+' C"B ,+' #('+,"A
AG
%/
&
+
!' "(@%
()% "(@%
"@ "(@%
!' "(@%
($!%% ) *% "(@%
( "(@%
,) ' %/*%!Q
( "(@ $ 0%
! "(@%
!'!
'#
777
44
14
4A
1>
77
J
42
J4
G
77
E
1>6
_
12D7
>D2
JDG
>DE
6DJ
1D2
4D4
EDA
44D4
7D6
1D2
7DA
722D2
#%$( *$%%&! $ ' %/ )MQ"$ (% $ "$! !8 * K127 _L !%8% )!
,) ' %/*%!Q 444 _D
?9
?96 C%+%CE#'A (+.# B ! 1>6 !3 " ! ! $ 0% ) ," J A2 " %%/
* &!% * " ) S ! "8($* ) 72J _D
"8($* 0$ #($ ( !)% "( ("" (!Q "((':
"%)'% $ 0%&!D * )(%' $$ ( * '"( (!Q !$( (!Q !$(
#% $ 0%&!D
?9?9 C%+%CE#'A ,+' ,L
#.#B 1 0 C%+%CE#'A ,+' ,L
Q
'%%
J ^
#
17
6
A2
_
GGDE
44DE
722D2
J
#
7G1
7E>
146
_
E4D>
AGDA
722D2
"
1D77
2D224G
! * ( &! $ /( ) Q '(*!$% " GGE _ )
" %%/ (! JD # * $(% ( !8 Q '(*!$% "8($* " %%8 ) J (8* ! 8($! " ) 2224GD
AJ
4 0 ?9>9C%+%CE#'A ' @+'A"+' S(
#.#B 11 0 C%+%CE#'A B ,+' S(
0
2E (
>72 (
777E (
7>42 (
J^
#
E
6
7G
6
A2
_
74DE
44DE
A4DE
44DE
722D2
J
#
62
62
J1
>>
146
_
4GDA
4GDA
4ED4
42D7
722D2
"
2D1J
2DGG
4D76
7D7>
2DA4AE
2DE74J
2D2421
2DG7G1
! * ( )( " "!$(% )M!) ! (!0'(% ) $( " " % )
!3 " %%/ ) 2 S 7E ( D( "8($* &!% ) 74E _ *@U $ 2E ( "(
44E_ *@U $ >72 ( "!% S A4E _ *@U $ 777E ( !% !
/$*@%' *@U $ 7>42 ( (8* 44E _D
( "8($* $( "$! $8 ( !8 )( $( (*@ )MR0 ) 777E (
(8* ! " f 22421D
"(%% ) $( "8($* $$ )( $ (*@ )MR0
#.#B 110 C%+%CE#'A %CC B #', , "%#'A-, S(
0
#
2E (
>72 (
777E (
7>42 (
6E
66
722
GE
1>6
%%/
E
6
7G
6
A2
_
E1
6
7G
74
72DJ
?97 C%+%CE#'A B ,+' B %C, 'A
#.#B 11 0 C#%""+' B ,+' B %C, 'A
A6
)
),
(<(
!%
!0(
% !#$
@%:
( (%
(('D
($
#
E6
4E4
6
G
42
71
>
1
1>6
_
7>D2
>J4
4DA
7D6
EDA
1DE
7D>
2DJ
722D2
J^
#
>
4J
2
7
2
4
4
7
A2
_
7ED2
G2D2
2D2
4DE
2D2
ED2
ED2
4DE
722D2
(#$(! ' &!M(! %8(! ) $( 0% ) (<( !8 $ "$! / (!Q )
"8($*D
Q'"$ -
"8($* )! J $ $ $%! ) %)* S (<(
#.#B 11 0 C#%""+' B ,+' B %C, 'A P #T#%
)
IDD
ID
ID
($
#
412
>
7>
4E4
_
67D1
4DA
>D1
722D2
J^
#
4>
2
4
4J
_
64D6
2D2
GD7
722D2
( &!(% ($% ) !3 " %%/ *! )( $ &!(% " "!$(%D
?9:9 C%+%CE#'A B ,+' # %+@,,+'
?9:969 C%+%CE#'A B ,+' # %+@,,+' B /%
*( $( " /% )! ": "('% $ A2 *( " %%/ 72 " /% M "( "*%D * %! ! 0('' ) " /% " % ($$( ) (
'"$ % (% (!Q (0 )M"%D
?9:9?9 C%+%CE#'A B ,+' # %+@,,+' # /%
'(0: "( $( "$! / " " % (8* >4E _ D
?9=9 C%+%CE#'A B " #('+,"A
#.#B 11 0 C#%""+' B ,+' #('+,"A
E2
4 0 %/ * J^
#
&
+
71
!' "(@%
7
()% "(@%
A
"@ "(@%
1
' "(@%
J
($!%% 2
) *% $ 0%
7
( %
2
,) ' %/*%!Q J
( "(@ $ 0D
7
! "(@%
2
!'!
7
A2
_
14DE
4DE
72D2
GDE
42D2
2D2
4DE
2D2
42D2
4DE
2D2
4DE
722D2
J
#
6J
47
4J
47
4J
77
G
42
GA
>
77
A
146
_
46DJ
>DA
JDE
>DA
JDE
1D1
4D7
>D7
44DE
7DJ
1D1
7D4
722D2
#
777
44
14
4A
1>
77
J
42
J4
G
77
E
1>6
_
12D7
>D2
JDG
>DE
6DJ
1D2
4D4
EDA
44DE
7D6
1D2
7DA
722D2
(#$(! ' &! $ " (0 ) J "! * Q% )M(! "(@ $ 0%D %%
$ " !*(0 $ "$! $8 !8 " ! $ ' %/ ) * !$(% * '' $ #%$( *$%%&! $ @' "(@% $ ,) ' %/*%!Q $ *()% "(@%D
?9< C%+%CE#'A B " -+,"#,#"+'
" (0 )! J ( !)% / *% ) $M@ "%($%(% ! ) "(% (!*! )%//* M( !8 * '' $ ' $ (#$(! gg
#.#B 110 C%+%CE#'A B ,+' -+,"#,#"+'2
"%($%(% )
!%
J^
#
7>
4A
A2
_
A2D2
>2D2
722
J
#
776
472
146
_
1>D4
>1DJ
722D2
7D7J
"
2D>1A6
?9 B"%, #%#/"%, .++(DB,
'' %)%&! )( $( '@ ) $ 0% $( "$!"( ) "(% ! 0($' )M(!
(($, #% $ 0%&! T (%% $( " %%8% ( !)% "( ("" S * )%//
"((':D ")( $( (%$$ ) *@(%$$ $ $ )%// (($, //*!
"'(% "( ) * *$! " ! $( "$!"(D
! ! (8 " ! $( 0$,*'% ! 717 "(% V
! 16 "( ! @,"0$,*'% A !3 (8(% ! $ 0% J " %%8
% K72D1_LD
V
! 7A "(% "( ! @," 0$,*'% A (8(% ! $ 0% J " %%8
E7
% K4JD>_LD
V
E4
/% 77J !3 ! ! 0$,*'% '($ ) A ! (!% ! $ 0%
J " %%8 K1DA_LD
4 0 4 0 !) ( " ! 1>6 !3 ) 2 S 42 ( ! 8( ) $ *!' M
//*! )!( $( "% ) ($$( ) X!%$$ S 8'# 4227 (! $(# ( % ) % $ 0% )
$MO"%($ )M/( $# F (!Q $(# ( % % *@%'% ) (*% $ 0% )
$M(#$%' !#$%* ) ( %%) D ! (8 *!%$$% $ ( !
"$('( ) * "(% &!% , (% %%%($' % " ! )%8 (($, ,
(8 *@*@ $( "8($* )! 8%! @"%&! ," JD
! (8 !%$% $( (*% )M''! /$! ** )%* (8* $ <% )
$(# ( % - ! ("%) %#$ )M! 0() //%*(*%D
(%* " K*L *@*@ $ * (% %0: $(D
( "$!"( ) "(% *! S $M@O"%($ $# F )( $ 0 !"
) 27E ( "( * $ 0 !" 7>42 ( ( Q*$!%8' *! S
$M(#$%' !#$%* ) ( %%) D
! * !) ! "8($* 0$ #($ ) 72J_ ( !8D $$*% (
' ! (!0'(% $%(% / *% ) $MR0 !%8% )M! /$*@%' S "(% )
$MR0 ) 7E (D #8(% 3 % $ (8(!Q ' /%&! *($ "(
(% 5?G8 (! (' ! 7666 )( $&!$ %$ ( ' &!M (": $( ('%% "(%8 ) 0 '($ $( "8($* )%'%! " ! (!0' 8 $MR0 )
74 ( *% 3!%/% &!M%$ Q% " #(#$' /%&! ! (! ' ) ) ('%% Q!$$ ")( $M/(* * '' $ !00: 0($' $ 766J )( !) N('#% 5=G8D ' ) ) ('%% (% )! S $( " '%*!% S $(
E1
"*(% @," @: 3 % $ (8(%$ ) (,('( ' !0()( 766J ` %$ (
' &! $( ('%% " !8(% W /(*%$% "( $ * )%% ) 8% * '' )*%
" ! $ *( ) $( ('%% )! 8%! $M@"(% 5:8 D M%/$!* ) $( "*(%)!
%8(! *% * '%&! )( $( ('%% )! J 0($' $( )( $
!$( ) $M!) ) %( \ 4227 /%&! )! !) 5=8
)@ )! * % (/%*(% (%$$(0 4224 ( ' ! ('%% Q!$$ *@U ) /( Q( ) A S 71 (D 578
": $MR0 ) 7E ( !8 $( "8($* $M()!$ )( !) " !
* (*@ )MR0 ! "8($* ) 74_ ( !8 * /%'( *$$ )
(,%($$ ($% S (<( *@U $ /'' *% &!% (8(% 8$ !
"8($* ) 7A1_D 5?8
" "!$(% )M!) (% '(3 %(%' * %! ) !3 ) Q '(*!$%
%$ (""(! ! * $(% /(*@ K"f2224GL $( " %%8% J $ Q
'(*!$%D &!% (** ) (8* $ (8(!Q ) '% D 4227 N('#% 56.,8 (
' ! ) *( ) (* ' ) (" % ")%(%&! * $$%0 ) 76>J S 766E K4J(L
&! $ (* ' ) (" % (% $ "$! !8 !8 *@U $ 3! 0(Z KJA_LD(
* 'W' (8(%$ %$ ( ' &! $ (* ' ) (" % ( $ "$! !8 !8 *@U
$ 2E(D $ ( 0($' !)% $M%/$!* )! ! $ (* ' ) (" % T (%% %$ (
!8 &!M(8* $M(8:' )! %)( $ '# ) (* ' ) (" % ( (!0' (8*
"f2221D
'' "(% *! S $( !% )M(! Q(' #% $ 0%&! )
( *%(% (8* $ "((': #% $ 0%&! //*! (!*! ( *%(% (%%&! M( !8 " ! $( "$!"(D ")( " ! $( 0$,*'% ! *(%
* $(% (8* $M@," 0$,*'% '#$ )%D !) ($% (! Q( "( 5>8
*@U ) /( ( *@*@ ! 8!$$ * $(% J $M%% *, )
*$$!$ ) (0@( %*%'% M( "! W * *$!( )! /(% )! /(%#$ '# )
"(%D
M%/*% S J ! $ "$( "%)'% $ 0%&! ( ' &! *@U $ ' % ) 7E
( $MQ%* )M! ' ) ) ('%% * *$(%' )'% T %$ (%
%( ) )%" )M! * @ ) !8(!Q 0(%/ ) $ !%8 )(
$ '" " ! !)% $ 8!$ ' ) ) ('%% $ )%// /(*!
( *% D
EA
!) ! $ %/*% S "8%! @!'(% ," J (! 0($ )( ! (8(%$
"$%'%(% *@U $ /'' *% ' ! "8($* ) 7A1_ )!
J T '(% "( * $( "8($* *@U $ !3 ) 2 S 42 ( ! ! *@U
$ /( ) 2 S 7E ( )'! %* ! (! 0($D
! (8 "% ) ' ! !) (8($ *@U * " "!$(% (/% ) V
'% $( "8($* )! J )( * " "!$(% V
'% $ "(%*!$(% ) $M%/*% S J / *% ) "((': !)%
V
" ) (Q )M!) &!% "' ) '%!Q * '") $ ' ) )
('%% )! JD
M ! (8(%$ ($% (! $(# ( % ) (*% $ 0%% $ 0% ) $M(#$%' "!#$%*
%%) (*D
( "8($* J ( )'% "( ! '@ ) )M%''! /$! **
%)%* !%$%( ! <% ) (# ( % K /* - 7E112222L
! $ ) (%%&! *($*!$ (8* ! %8($$ ) * /%(* )
6E_ K @%4 )) (% " L
" "!$(% )M!) * %! ) 1>6 !3 ) 2 S 42( "(% A
0 !" -
EE
V
2 S E ( (8* 6E !3
V
> S 72 ( (8* 66 !3
V
77 S 7E ( (8* 722 !3 V
7> S 42 ( (8* GE !3
"$:8' '(3 %(%' *! (! $(# ( % ) #% $ 0% $MO"%($
)M/( $# F KL " ! $ K27E (L Q*$!%8' ) $(# ( % )
#% *@%'% ) #(*% $ 0%% $ 0% ) $M(#$%' !#$%* ) ( %%) " ! $ 7>42(D
! (8 "(($$:$' *!%$$% %0' "%)'% $ 0%&! $ !$(
) (($, " ! $&!$$ $ "(% /! %%%($' % 8 * 8%*D
( "8($* 0$ #($ !8 ( ) 72J _D
! (8 ! * %(* ) $( " %%8% )! J *@U $ K27E(L `
$$ "( ) 74E_ S A4E_ *@U $ K777E(L "!% ! /$*@%' *@U $
K7>42(L S 44E_D
"$! ( ! * $(% /(*@ $( " %%8% " %%8 J $MR0
)( $( (*@ ) K777E(L * &!% ! ( /(% * *$! &!M! "(% ) $(
"8($* J )( $( (*@ )MR0 ) 2E ( $% S $( ('%% "(%8
) 0 '($$ K':/(L )( $ (*@ )MR0 !%8( S !
('%% @ %U ($ Q!$$D
M!) ) $( "8($* $ $ $%! ) %)* $( " /% ) "( $ )%(0 %* M( "( ' ) * $(% !/ % $ *!' '(3 %(% ) !3
" %%/ (! J )( $ &!(% " "!$(% )( $ * !*@ ' , S
)/(8 % (8* ! %8(! )M%!*% !$ S ' , !00: ! %'"$%*(% )! %8(!
*% * '%&! )( $( ('%% @ %U ($ ) JD
( * $(% ) $( "8($* / *% ) "((': #% $ 0%&! '#$
' ! ( *%(% (8* $( 0$,*'%D
!$( %! ) * (8(%$ !00: ) " *) S ) !) !$%! (//%( $ "((': )M%8%0(% ) /(Z -
V
' 8%)* ! 8!$$ ('%% ! $ % )! J !%8(
! * @ )M/( ): $( (%(*
V
/%' $M%/$!* ) * )%% *% * '%&! * '' /(*! ) %&!
V
$ $( " %%8% (! J S *(% "(@ $ 0%D
! )! /(% ) $M(*!% * %( &! 8( (8 % $ 8%! @"%&! ," J * '" !
) $( "()'% )! %)( %$ (% (!% 3!)%*%!Q ) ,'(% $ )"%(0 (! 'W'
% &! $M%/*% (! ;
%)( &! $M@"(% *@U $( /'' *% $ ) ! )
(0 $ " $,(/! ) /(Z (!Q (! !3 S @(! %&! (/% -
E>
V
)M 3!0!$ $M%'"(* ! $( ( "!#$%&!
V
)M $%'% $( " "(0(% "(%*!$% *@U $ /( V
)M8%(0 ) '! ) "8% $$ &! $( 8(**%(% D
BIBLIOGRAPHIE1- ABLASHI DV., CHATLYNNE L. ,THOMAS D. , BOURBOULIA D. ,
RETTIG MB., VESCIO RA. , VIZA D., GILL P., KYLE RA., BERENSON JR.,
WHITMANN JE.
Lack of serologic association of hhv8 in patients with monoclonal gammo pathy of
undetermined significance with and without progression to multiple myeloma.
Blood. 2000 ; 96 (6) : 2304-6
1-bis AMIR H, KAAYA EE, MANJI KP, KWESIGABO G, BIBERFELD P
Kaposi’s sarcoma before and during a human immunodeficiency virus epidemic in
Tanzanian children.
Pediatr infect Dis J 2001 May; 20(5): 518-21
2- ARIYOSHI K. SCHIM VANDER LOEFF M., COOK P., CORRAH T., JAFFAR S.
CHAM F., SABALLY S., O’DONOVAU D., WEISS R.A., SCHULZ T.F., AND WITTLE
H.
Kaposi’s sarcoma in the Gambia, West Africa is less frequent in Human
Immunodeficiency virus type 2 than Human Immunodeficiency virus type 1 infection
despite a high prevalence of Human Herpesvirus 8.
J. Human Virol. 1998 ; 1 (3) : 193-9.
AZZI A. FANCI R., DE SANTIS R., CIAPPI S., PACI C., LONGO G., FERRINI P.R.
HHV8 and multiple myeloma : ORF 26 and ORF K1 sequences detection in bone
marrow stromal cells.
XXIIIrd meeting of the European Tumor Virus Group, Inst. Pasteur, Paris, France 9-12
June, 1999 ; abstract 10/67.
BAILLARGEON J, LEACH CT, DENG JH, GAO SJ, JENSON HB
High prevalence of human herpesvirus (HHV-8i infection south Texas children.
J Med Virol 2002 ; 67 (4) : 542-8
4bis- BERAL V., PETERMAN T.A., BERKELMAN R.L., JAFFE H.W.
Kaposi’s sarcoma among persons with AIDS : a sexually Transmitted infection ?
Lancet 1990 ; 335 : 123-28.
5-BESTETTI G. RENON G., MAUCHERE P., RUFFIE A., KEOU F.X.M., PARRA VICINI
C., EME D., CORBELLINO M., DE THE G., AND GESSAIN A.
High seroprevalence of Human Herpesvirus 8 in pregnant women and prostitutes from
Cameroon.
J. AIDS 1998 ; 12 (5) 19 : 541-3.
6-BLACKBOWN D.J., OSMONO D., LEVY J.A., AND LENNETTI E.T.,
Increased Human Herpesvirus 8 seroprevalence in young homosexual men who have
multiple sex contacts with different partners.
J. infect. Dis. 1999 ; 179 : 237-9.
7-BLACKBOWN D.J., LENNETTI E.T., AMBROZIAK J., MOURICH D.V. AND LEVY
J.A.
EG
Human Herpesvirus 8 detection in nasal secretions and saliva.
J. Infect. Dis. 1998 ; 177 : 213-6.
8-BLACKBOWN D.J. AND LEVY A.J.
Herpesvirus 8 in semen and Prostate.
J. AIDS 1997 ; 11 : 249-50.
9-BOULANGER E.
Human Herpesvirus 8 (HHV8) : caractérisation et épidémiologie.
Ann. Biol. Clin. 1998 ; 56 (6) : 643-50.
10-BOURBOULIA D., WHITBY D., BOSHOFF C., NEWTON R., BERAL V., CARRARA
H., LANE A., SITAS F.
Serologic evidence for mother-to-children transmission of Kaposi sarcoma-associated
Herpesvirus infections.
JAMA, 1998 ; 280 (1) : 31-2.
11-brambillal l. , boneshi v. , ferrucci s. , taglioni m. , berti e.
hhv8 among heterosexual partners of patients with Classical Kaposi’s Sarcoma
Br.j.dermatol.2000 ; 143(5) :1021-25
12-campbell tb. , borok m. , gwanzura l . , ma whinney S., white ie. , ndemera b., gudza
i., schooley rt.
Relationship of hhv8 peripheral blood virus load and Kaposi’s sarcoma clinical stage
aids.2000 ; 14 (14) : 2109-16
13-CESARMAN E., CHANG Y., MOORE P.S., SAID J.W., AND KNOWLES D.M.
Kaposi’s sarcoma – associated Herpesvirus like DNA sequences in AIDS – related
Body Cavity – Based Lymphomas
N. Engl. J. Med 1995 ; 332 (18) : 1186-90.
14-CHANG Y., CESARMAN E., PESSIN M.S., LEE F., CULPEPPER J., KNOWLESS
D.M., MOORE P.S.
Identification of Herpesvirus –like DNA sequences in AIDS – Associated kaposi’s
sarcoma.
Science. 1994 ; 266 : 1865-9.
15-CHUCK S. GRANT R.M., MBIBDE E.K., CONANT M., GANEM D.
Frequent presence of a novel Herpesvirus genome in lesions of Human
Immunodeficiency Virus – Negative Kaposi’s sarcoma.
J. Infect. Dis. 1996 ; 173 : 248-51
16-COLABRO M.L., SHELDON J., FAVERO A., SIMPSPN G.R, FIORE R., GOMES E.,
ANGARANO G., CHIECO – BIANCHI L. AND SCHULZ T.F.
Seroprevalence of Kaposi’s sarcoma associated Herpesvirus / Human Herpesvirus 8 in
several regions of Italy.
J. Human. Virol. 1998 ; 1 (3) : 207-13.
17-Comité Scientifique groupe séroépidémiologique du Programme national de Lutte
EJ
contre le SIDA au Sénégal.
Bulletin Epidémiologique HIV (SIDA)
Juin 1999 ; 7 : 36 p.
18-Comité Scientifique groupe séroépidémiologique du Programme national de Lutte
contre le SIDA au Sénégal.
Bulletin Epidémiologique HIV (SIDA
Décembre 1997 : 6 : 35 p.
19-COURS DE VIRILOGIE MEDICALE : 2ème édition 1989.
Les Herpesviridae : Généralités 109-12.
20-Deng H. , Young A. , Sun R.
Auto-activation of the rta gene of hhv8.
j.gen. virol. 2000 ; 81 (12) : 3043-48
21-DESROSIERS R.C., SASSEVILLE V.G., CZAJAK S.C., ZHANG X., MANS FIELD
K.G., KAUR A., JOHNSON R.P., LACKNER A.A., AND JUNG J.U.
A Herpesvirus of Rhesus Monkeys Related of the human kaposi’s sarcoma –
associated Herpesvirus.J. Virol. 1997 ; 71 (12) : 9764-9.
22-DUPON M., MASQUELIER B., CAZORLA C., CHENE G., DUMON B., RAGNAUD
J.M. de FLEURY HJ.
Acquired immunodeficiency syndrome associated kaposi’s sarcoma and human
herpesvirus 8 DNA detection in serial peripherial blood mononuclear cell samples.
Res. Virol. 1997 ; 148 (6) : 417-25.
23-DUPIN N., GRANDADAM M., CALVEZ V., GORIN I., AUBIN J.T., HAWARD S.,
LAMY F., LIEBOWITCH M., HURAUX J.M., ESCAUDE J.P., AGUT H.
Herpesvirus – like DNA sequences in patients with Mediterranean Kaposi’s sarcoma.
Lancet 1995 ; 345 ( 8952) : 761-2.
24-Engels EA . , Sinclair MD., BIGGAR RJ., whitby D. , Ebbessen P. , GOEDERT JJ. ,
Gastwirth JL.
Latent class analysis of human herpes virus 8 assay performance and infection
prevalence in Sub-Saharan Africa and MALTA.
Int.J. cancer. 2000 ; 88 (6) : 1003-08
25-GALLO ROBERT C.
HIV-1, HHV8, and Kaposi’s sarcoma.
J. Human. Virol. 1998 ; 1 (3) : 185-186.
26-GAO S.J., KINGSLEY L., LI M., ZHENG U., PARRAVICINI C., ZIEGLER J.,
NEWTON R., RINALDO C.R., SAAN A., PHARI J., DETELS R., CHANG Y. AND
MOORE P.S.
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi’s
sarcoma.
Nature Med. 1996 ; 2 (8) : 925-8.
E6
27-GAO S.J., KINGSLEY L., HOOVER D.R., SPIRA T.J., RINALDO C.R., SAAM A.,
PHAIR J., DETELS R., PARRY P., CHANG Y., MOORE S.P.
Seroconversion to antibodies against Kaposi’s sarcoma – associated Herpesvirus
Related Latent Nuclear antigens before the Development of kaposi’s sarcoma.
N. Engl. J. Med. 1996 ; 335 (4) : 233-41.
28-Gaye Diallo A., Toure A.T., GESSAIN A., GUEYE-Ndiaye A.,
N’DOUR A.N., TOURE-KANE N.C., DIA M.C.,DE THE G. AND
MBOUP S.
Preliminary study of Human Herpesvirus type 8 infection in antenatal clinic attendees in
Dakar.
Bull Soc Pathol Exot, 2001, 94, 3, 231-34
29-GESSAIN A., MAUCLERE P., BEVEREN M.V., PLEUCOULAINE S., AYOUBA A.,
ESSAME-OYONO J.L., MARTIN P.M.V., AND DE THE G.
Human Herpesvirus 8 primary infection occurs during childhood in Cameroon, central
Africa.
J. Nat. Cancer 1999 ; 189-192.
30-GESSAIN, A., BRIERE J., ANGELIN-DUCLOS C., VALEUSI F., MERLE BERAL H.,
DAVI F., NICOLA M.A., SUDAKA A., FOUCHARD N., GABARRE J., TROUSSARD
X., DULMENT E., AUDOUIN J., DIEBOLD J., AND THE G.
Human Herpesvirus 8 (Kaposi’s sarcoma herpesvirus) and malignant
lymphoproliferations in France : a molecular study of 250 cases including two
AIDS-associated body cavity based Lymphomas.
Leukemia 1997 ; 11 :266-72.
31-GRANDADAM M., DUPIN N., CALVEZ V., GORIN I., BLUM L., KERNBAUM S.,
SICARD D., BUISSON Y., AGUT H., ESCANDE JP., HURAUX JM.
Exacerbations of clinical symptoms in human immunodeficiency virus type-1 infected
patients with multicentric Castleman’s disease are associated with a high increase in
Kaposi’s sarcoma Herpesvirus DNA load in peripheral blood mononuclear cells.
J. Infect. Dis 1997 ; 175 (5) :1198-01.
32-GREENBLATT RM.
Kaposi’s sarcoma and human herpesvirus 8.
Infect. Dis. Clin. North Am. 1998 ;12 (1) :63-82.
33- Hong A., Lee. Cs
The emerging role of the HHV8 in human neoplasia
Pathology. 2001 ; 33 (4) : 461 –8
34-Irene E. white and Campbell T.B.
Quantitation of cell-Eree and Cell associated Kaposi’s Sarcoma-Associated Herpesvirus
DNA by peal time PCR
Tourned of Clinical. Microbiology. 2001 ; 38 (5) : 1992 –1995
35-Iscovich U ; Boffetta P ; Franceshi S ; AZIZIE ; Sarid R. Classic Kaposi sarcoma :
>2
epidemiology and risk factores.
Cancer. 2000, 88 (3) : 500 – 17
36-IH-JEU S., SHIAU S.Y., CHANG Y., WANG I. W.
Herpesvirus-like DNA sequence in Kaposi’s sarcoma from AIDS and non-AIDS patients
in Taïwan.
Lancet 1995 ;345 (8951) :722-3.
37-Jenkins Fj., Hoffman Lj., Liegey. S., Doungall a. Reactivation of and primary infection
with HHV8 among solid-organ transplant recipients.
J. infect. Dis 2002 ; 185 (9) : 1238 – 43
38- JENSON HB, MCCLAIN KL, LEACH CT, DENG JH, GAO SJ.
Evaluation of human herpesvirus type 8 infection in childhood langerhans cell
histiocytosis.
Am J Hematol 2000 ; 64(4) :237-41
38-bis junsoo p. , taegun s. , seungmin h. , deyoup l. , youssang g. , joonho c.
The k-bzip protein from Kaposi’s sarcoma-associated herpes virus interacts with p 53
and represses lts transcriptional activity
J. virol. 2000 ; 74 (24) : 11977-82
39-KASOLO F-C., MONZE M., OBEL N., ANDERSON R.A., FRENCH C., AND
GOMPELS U.A.
Sequences analyses of Human herpesvirus 8 strains from both Africa Human
Immunodeficiency Virus negative and positive childood endemic Kaposi’s sarcoma
show a close relationship with strains identified in febrile children and high variation in
the K11 glycoprotein.
J.General. Virol 1998 ;79 : 3055-65.
40-KEDES, DEAU H., GANEM, AMELI, NILOUFAR, BACCHETTI, PETER,
GREENBLATT, RUTH.
The prevalence of serum antibody to Human herpesvirus 8 (kaposi sarcoma associated
Herpesvirus) among HIV seropositive and High risk HIV seronegative women.
JAMA 1997 ; 277 (6) : 478-81.
41-KEDES D.M., OPERSKALSKI E., BUSCH M., KOHN R., FLOOD J., AND GANEM
D.
The seroepidemiology of human Herpesvirus 8 (kaposi’s sarcoma associated
Heerpesvirus) : Distribution of infection in sarcome de Kaposi risk groups and
evidence for sexual transmission.
Nature Med. 1996 ;2 (8) : 918-24.
42-KELLAM P., BOSHOFF C., WHITBY D., MATTHEWS S., WEISS R.A., AND
TALBOT S.J.
Identification of a Major Latent Nuclear Antigen, LNA-1, in the Human Herpesvirus 8
Genome.
J.Human Virol. 1997 ;1 (1) :19-29.
>7
43-KOELLE D.M., HUANG M.L., CHANDRAN B., VIEIRA J., PIEPKORN M., AND
COREY L.
Frequent detection of Kaposi’s sarcoma Associated herpesvirus (Human Herpesvirus 8)
DNA in saliva of human Immunodeficiency Virus infected men : clinical and
immunology correalates.
J. Infect. Dis. 1997 ;176 :94-102.
44-LACOSTE V., JUDDE J.G., BRIERE J., TUILIEZ M., GARIN B., COUPIE P., CLYTI
E., VILA J.F., DELMER A., MAUCHERE P. and GESSAIN A.
Genetic variability of KHSV K1 gene according to diseases and geographical origin : a
study of 50 new strains.
XXIIIrd meeting of the European tumor-Virus Group, Inst. Pasteur, Paris, France 9-12
june, 1999 ; abstract 10/65.
45-LAGUNOFF M. AND GANEM D.
The structure and coding organization of the Genomic Termini of Kaposi’s
sarcoma-associated herpesvirus (human Herpesvirus 8).
J. Virol 1997 ; 236 :147-54.
46-Lam LL., Pau CP., Dollard SC., pellet PE., Spira TJ.
Highly sensitive assay for HHV8 antibodies that uses a multiple antigenic peptide
derived from open reading frame K 8.1
J. Clin. Mi crobiol. 2002 ; 40 (2) : 325 – 9
47-Leao JC., Porter S. , Scully C.
human herpes virus and oral health care : An update.
Oral surg oral Med oral pathol oral Radiol Endod. 2000 ; 90 (6) : 694-704
48-LEE H., GUO J., LIM., CHOL J.K., DEMARIA M., ROSENZWEIG M., AND JUNG
J.U.
Identification of an immunoreceptor tyrosine-based Activation Motif of K1 Transforming
Protein of Kaposi’s sarcoma-associatied herpesvirus.
Md. Cell. Biol 18 (9) : 5219-28.
49-LEE H., VEAZEY R., WILLIAMS D., GUO J., M., NEIPEL F., FLECKEINSTEIN B.,
LACKNER A., DESROSIERS R.C., AND JUNG J.U. Deregulation of cell growth by
the K1 gene of Kaposi’s sarcoma associated Herpesvirus.
Nature Med. 1998 ;4 (4) :435-40.
50-LENNETTE E.T., BLACKBOWN D.J., LEVY J.A.
Antibodies to Human Herpesvirus type 8 in the general population and in the Kaposi’s
sarcoma patients
Lancet 1996 ;348 :858-61.
51-lim c. , sohn h. , gwack y. , choe j.
Latency-associated nuclear antigen of HHV8 binds ATF4/CREB 2 and inhibits its
transcriptional activation activity
J.gen.Virol.2000 ; 81(11) : 2645-52
>4
51bis-LISITSYN NIK., LISITSYN NAT., WLIGLER M.
Cloning the difference between two complex genomes.
Science 1993; 259 ( 5097):946-51
52-luppi m. , barozzi p. , schulz tf. , trovator r. , donelli a. , narni f. , sheldon j. ,
marascar. , torelli g.
Nonmalignent disease associated with HHV8 reactivation in patients who have
undergone autologous peripheral blood stem.cell trasplantation
Blood.2000 ; 96(7) : 2355-7
53-Luppi M. , Barrozi P. , Santagastino G. , Trovato R. , Schulz TF . , Marasca R. ,
Bottalico D. , Bignardi L. , Torrelli G.
Molecular evidence of organ-related transmission of hhv8 in transplant patients.
Blood. 2000 ; 96 (9) ; 3279-81
54-ma. Hj. , sjak- shie nn. , vescio ra. , kaminsky m . , mikail a. , pold m. , beksac m. ,
belson d. , berenson jr.
Hhv8 ORF 26 and ORF 65 of Myeloma multiple patients.
Clin. Cancer. Res. 2000 ; 6 (11) : 4226-33
55-MANN A., STRICKLER H.D., HANCHARD B., MANASSARAM D.M., WATERS D.,
ABLASHI D.V.
Age – and –sex-specific seroprevalence of human herpesvirus 8 in Jamaica.
J. Nat. Cancer Inst. 1998 ; 90 (14) : 1102-3.
56-MARTIN J.N., GANEM D.E., OSMOND D.H., PAGE-SHAFFER K.A., MACRAE D.,
KEDES D.H.
Sexual transmission and the natural history of Human herpesvirus 8 infection N. Engl. J.
med. 1998 ; 338 : 948-54.
57-masini c., abeni dd., cattruzza ms., capuano m., fadda g., cattani p.
Autibodies against hhv8 in subjects with non-veneral dermatological conditions.
Br.j. dermatol.2000 ; 143 (3) : 484-90
58-MAYAMA S., CUEVAS L.E., SHELDON J., OMAR H.O., SMITH D.H., OKONG P.,
SILVEL B., HART C.A., AND SCHULZ T.F.
Prevalence and transmission of Kaposi’s sarcoma-associated herpesvirus (Human
Herpesvirus 8) in Ugandan children and adolescents.
J. Nat. Cancer Inst. 1998 ; 77 817-20.
59-MESRI E.A., CESARMAN E., ARVANITAKIS C., RATII S., MOORE M.A.S.,
POSNETT D.N., KNOWLES D.M., AND ASCHA.S.
Human Herpesvirus-8 / Kaposi’s sarcoma-associated herpesvirus is a new
transmissible virus that infects B cells.
J.Med. 1996 ; 183 :2385-90.
60-MILLER G., RIGSBY M.O., LEE H., GROGAN E., REU S., CRAIG M., LEVY J.A.,
SHOU J.G., CHANG Y., MOORE P.
>1
Antibodies to butyrate-inducible antigens of Kaposi’s sacroma-Associated Herpesvirus
in Patients with HIV –1 Infection.
N. Engl. J. Med. 1996 ; 334 (20) : 1292-7.
61-MILLER M.J.
Viral taxonomy
Clin. Infect. Dis. 1995 ; 21 : 279-80.
62-MOORE P.S., GAO S.J., DOMINGUEZ G., CESARMANT E., LUNGU O.,
KNOWLES D.M., GARBER R., PELLETT P.E., MC GEOCH D.J., AND CHANGY.
Primary characterization of a Herpesvirus agent associated with Kaposi’s sarcoma.
J. Virol. 1996 ; 70 (1) :549-58.
63-NEIPEL FRANK, ALBRECHT J-C AND FLECKEUSTEIN B.
Human Herpesvirus 8 the first Human Rhadinovirus.
J. Nat. Cancer Inst. 1998;23:73-7
64-NEIPEL, ALBERCHT J-C AND FLECKEUSTEIN B.
Cell-homologous Genes in the Kaposi’s sarcoma- Associated Rhadinovirus Human
Herpesvirus 8 Determinants of its pathogenicity.
J. Virol 1997 ;71 :4187-92.
65- NIANG A.
La maladie de kaposi à Dakar.
Thèse Med. Dakar 1997 ;42.
66-NICHOLAS I., ZONG J.C., ALCENDOR D.J., CINGO D.M., POOLE L.J., SARISKY
R.T., CHIOU C.J., ZHANG X. , WAN X., GUO H.G., REITZ M.S., HAYWARD G.S.
Novel organizational features, captured cellular genes, and strain variability within the
genome ofKSHV/HHV8.
J. Nat. Cancer Inst. 1998 ;23 :79-88.
67-nUnez m., machuca a., soriano v., podzamozer d., gonzalez-lahoz j.
Clearance of hhv8 viraemia in hiv-1-positive patients with Kaposi’s sarcoma treated with
liposomal doxorubicin
aids . 2000 ; 14 (8) : 913-9
68-oksenhendler e., carcelain g., aoki y., boulanger e., agbalika f.
High level of hhv8 viral load, human interleukin-6, interleukin-10 and
C-reactive protein correlate with exacerbation of multicentric castleman disease in
hiv-infected patients
Blood. 2000 ; 96 (6) 2069-73
69-Olsen SJ ; Chang Y, Moore PS ; BIGGAR RJ ; Melbye M.Kaposi’s sarcoma
associated herpes Virus seroprevalence with age in a lighly Kaposi’s sarcoma
endemic region, Zambia in 1985.
AIDS 1998 ; 12 (14) : 1921 – 5
70-Parisi SG., Sarmati L., pappagallo M., Mazzi R., Carolo G. , Farchi F. , Nicastri E.,
>A
Concia E., Rezza G., Andreani M ;
Prevalence trend and correlates of HHV8 infection in HIV infected patients
J.Acquir-Immune Defic Syndr 2002 ; 29 (3) : 295- 9
71-PARRAVICINI C., POLI F., BESTETTI G., LAURI E., SIRCHIA C., BERTI E.,
PIAZZA M., SCALAMOGNA C., MORONI M., GALLI M. and CORBELLINO M.
Risk of Kaposi’s sarcoma devlopment in renal transplant patients from Northern Italy.
XXIIIrd meeting of the European Tumor Virus Group, Inst. Pasteur, Paris, France 9-12
June, 1999 ; abstract 10/64.
72-Pauk J. , Huang ML ; Brodie SJ. , WALD A. , Koelle DM. , Schaker T. , Celum C. ,
Selkes. , Corey L.
Mucosal Shedding of hhv8 in Men.
N. Engl. J. Med. 2000 ; 343 (19) : 1369-77
73-PETERMAN T.A., JAFFE H.W. AND BERAL V.
Epidemiologic clues to the etiology of Kaposi’s sarcoma.
AIDS 1993. 7 : 605-11.
74-REANE R., LAGUNOFF M., ZHONG W., AND GANEM D.
The size and conformation of Kaposi’s sarcoma associatied Herpesvirus (Human
Herpesvirus 8) DNA in infected cells and virions.
J. Virol. 1996 ;70 (11) :8151-4.
75-RENNE R., ZHONG W., HERNDIER B., MCGRATH M., ABBEY N., KEDES D., AND
DON GANEM.
Lytic Groath of Kaposi’s sarcoma associated Herpesvirus (Human Herpesvirus 8) in
culture.
Nature Med. 1996 ;2(3) :342-6.
76-Renwick N ;Weverling GJ ; Halaby T ; Portegies P ; Bakker M ; Schul TF ; Gandsmit
J.
Kaposi’s sarcoma and HHV8 infection do not protect HIV-1 infected homosexual men
from AIDS dement Complex.
AIDS. 2000 ; 15 (16) : 2165 – 9.
77-RUSSO J.R., BOHENZKY R.A., CHIEN M.C., CHEN J., YAN M., MADDALLNA D.,
PANY J.P., PERUZZI D., EDELMA I., CHANG Y., AND MOORE P.
Nucleotide sequence of the Kaposi sarcoma associated Herpesvirus (HHV8)
Proc. Nath. Acad. Sci. 1996 ;93 :4862 –7.
78-saint paul ks. , ko-keung ng. , cheung lk. , augustine f.
hhv8, un nouveau membre du genre rhadinovirus dans la sous-famille des gamma
herpes virinae.
J. clin microbiol. 2000 ; 38 (7)
79-SANTARELLI R., ANGELONI A., FARINA A., GONELA R., GENTILE G., MARTINO
P., PETRUCCI M.T., MANDELLI F., FRATI L., FAGGIONI A.
>E
Lack of serologic association between Human Herpesvirus-8 infection and Multiple
Myeloma and Monoclonal Gammopathies of undermined significance.
J. Nat Cancer Inst. 1998 ;90 (10.) :781-2.
80-SCHALLING M., EKMAU M., KAAYA E.E., LINDE A., AND BIBERFELD P.
A role for a new Herpesvirus (KSHV) in different forms of Kaposi’s sarcoma.
Nature Med. 1995 ;1 (7) :707-8.
81-SCHULZ T.F., AND MOORE P.S.
Kaposi’s sarcoma-associated Herpesvirus a new human tumor virus, but now ?
Microbiol. 1999 ;7 (5) :196-200.
82-SCHULZ T.F., COOK P.M., GLEEN M., RAINBOW L., WHITBY D., CALABO M.L.,
LUPPI M., KAKOALA D. and DAVIDSON A.
Variability of KHSV/HHV8 in different genomic regions in Europe and Africa. XXIIIrd
meeting of the European Tumor Virus Group, Inst. Pasteur, Paris, France 9-12 June,
1999 ; abstract 9/61.
83-Serraino # ; Tomo L ; Andreoni M ; Butto S ; Tchangmena O ; Salmato L ; Monini P ;
Flanceschi S ; Eusoli B ; Rezza G.
A seroprevalence study of HHV8 in eastern and Central Africa and in the Mediterranean
area
Eur.J. epidemiol. 2001 ; 17 (9) : 871 – 6
84-SIMPSON G.R., SCHULZ T.F., WHITBY D., COOD P.M., BOSHOFF C., RAINBOW
L., HOWARD M.R., GAO S-J., BOHEUZKY R.A., SIMMONDO P., WELLER I.V.D.,
WEISS R.A., MOORE P.S.
Prevalence of Kaposi’s sarcoma associated Herpesvirus infection measured by
antibodies to recombinant capsid protein and latent immunofluorescence antigen.
Lancet 196 ;349 :1133-38.
85-SITAS F., CARRARA H., BERAL V., NEROTON R., REEVES G., BULL D.,
NORMAN R.P., BOURBOULIA D., WHITBY D., BOSHOFF C., AND WEISS R.
Antibodies against Human herpesvirus 8 in Black south Africa patients with cancer.
N. Engl. J. Med. 1999 :340 (24) :1863-71.
86-Sitas F ; Newton R
Kaposi’s sarcoma in South Africa
J. Nat. Cancer.inst.Monogr 2001 ; (28) : 1 – 4
87-SMITH M.S., BLOOMER C., HORVAT R., GOLDSTEIN E., CASPARIAU JM.,
CHANDRAN B.
Detection of Human Herpesvirus 8 DNA in Kaposi’s sarcoma lesions and peripheral
blood of human immunodeficiency virus-positive patients and correlation with
serologic
J. Infect. Dis. 1997 Jul. ;176 (1) : 84-93.
88-TARTE K ., BERNARD K.
Le Myelome Multiple : un nouveau cancer induit par un virus ?
>>
Med/Science 1998 ;14 :736-41.
89-tedeshi r. , caggiari l. , silins i. , kallings i. , andersson-Ellstrom. A. , de paoli p. ,
dillner j.
Seropositivity to hhv8 in relation to sexual history and risk of sexually to sexual history
and risk of sexually transmitted infections among women.
Int j. cancer.2000 ; 87 (2)
90-Thoda S., Murakami N., Nara N
HHV8 DNA in HIV-negative Japanese patients with multiple centric Castleman’s
disease and related diseases
Int. J. mol. Med. 2001 ; 8(5) : 549- 51
91-Treurnicht FK., Engel brecht S ;, Taylor MB., Scheider Jw., Vanren’sburg Ej.
HHV8 subtypes in South Africa : identification of a case suggesting a novel B variant
J.med Virol. 2002 ; 66 (2) : 235- 40
92-TROVATO R., LUPPI M., BAROZZI P., DA PRATO L. MAIORANA A., LICO S.,
MARASCA R., TORRICELLI P., TONELLI G., AND CECCHERINI- NELLI L.
Cellular localization of Human Herpesvirus 8 in Non neoplastic lymphadenopathies and
chronic interstitial Pneumonitis by in situ polymerase chain reaction studies.
J. Human. Virol. 1999 ;2 (1) :38-44.
93-WERNIG F., LANG M.E., ROTH B., FIORELLY V., SEPP N., ENSOLI B. AND
SCHWARZ S.
Pregnancy urine-hCG prepartions for treatment of AIDS – Kaposi’s sarcoma XXIIIrd
meeting of the European Tumor Virus Group, Inst. Pasteur, Paris, Paris, France 9-12
June, 1999 ; abstract 10/66.
94-WHITBY D., SMITH N.A., MATTHEWS S., O’SHEAS S., SABIN C.A.,
KULASEGARAM R., BOSHOFF C., WEISS R.A, RUITER A. DE, AND BEST J.M.
Human Herpesvirus 8 : seroepidemiology among women and detection in the
J. Infect. Dis. 1999 ;179 :234-6.
95-WHITBY D., LYPPI M., BAROZZI P., BROSHOFF C., WEISS R.A., TORELLI G.
Human Herpesvirus 8 : seroprevalence in Blood Donors and lymphoma Patients from
different regions of Italy.
J. Nat. Cancer Inst. 1998 ; 90 (5) : 396-7.
96-WHITBY D., HOWARD M.R., TENTANT-FLOWERS M., BRINK N.S., COPAS A.,
BOSHOFF C., HATZIOANNOUNT T., SUGGETT 103-F.E.A., ALDAM D.M.,
DENTON A.S., MILLIER R.F., WELLER I.V.D., WEISS R.A., TEDDER R.S., SHULZ
T.F.
Detection of Kaposi sarcoma associated Herpesvirus in peripheral blood of HIV infected
individuals and progression to Kaposi’s sarcoma.
Lancet 1995 ; 346 :799-02.
97-wu l. ; lo p., yu x., stoops jk., forghani b., zhou zh.
Three dimensional structure of hhv8 capsid
>G
J. virol. 2000 ; 74 (20) : 9646-54
98-YARCHOAM R.
Therapy for Kaposi’s sarcoma : recent advances and experimental approches.
J. AIDS 1999 ;2166-73.
99-yousang g. , hyewon b. , seungmin h. , chunchun l. , joonho c.
CreB- Binding protein and histone deacetylase regulate the transcriptional activity of
Kaposi’s sarcoma-associated herpes virus open reading frame 50.
J. virol. 2001 ; 75 (4) : 1909-17
100-zago a. , bourboulia d. , viana mc. , collandre h. , dietze r. , boshoff c. , keller r.
Seroprevalence of hhv8 and its association with sarcoma Kaposi in Brasil.
Sex.transm.dis. 2000 ; 27 (8) : 468-72.
101-ZHONG W., WANG H., HERNDIER B., AND GANEM D.
Restricted expression of Kaposi sarcoma associated herpesvirus (human Herpesvirus
8) genes in Kaposi sarcoma.
Proc. Nath. Acad. Sci. 1996 ; 93 :6641-6.
102-Zhonghna yi.,
Quantitative analysis of HHV8 and expression of its genres in patients with multiples
myelome.
Xue Zahie. 2001 ; 81/20) : 1230 – 3
103-ZONG J.C., CINGO D.M., ALCENDOR D.J., WAN X., NICOLAS J., BROWING
P.J., RADY P.L., TYRING S.K., ORENSTEIN J.M., RABKIN C.S., SUI-J., POWELL
K.F., CROXSON M., FOREMAN K.E., NICKOLOFF B.J., ALKAN S., AND HAYWARD
G.S.
High-level variability in the ORF-K1 Membrane Protein Gene at the left end of the
Kaposi’s sarcoma-associated variants or Clades in different Human population.
J. Virol. 1999 ;73 (5) :4156-70.
>J